JP3255411B2 - Hair growth promoter - Google Patents

Hair growth promoter

Info

Publication number
JP3255411B2
JP3255411B2 JP50508292A JP50508292A JP3255411B2 JP 3255411 B2 JP3255411 B2 JP 3255411B2 JP 50508292 A JP50508292 A JP 50508292A JP 50508292 A JP50508292 A JP 50508292A JP 3255411 B2 JP3255411 B2 JP 3255411B2
Authority
JP
Japan
Prior art keywords
group
benzopyran
dimethyl
nitro
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP50508292A
Other languages
Japanese (ja)
Inventor
弘 古賀
博之 名畑
博道 仁科
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of JP3255411B2 publication Critical patent/JP3255411B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth

Description

【発明の詳細な説明】 技術分野 本発明は、優れた発毛促進効果を有するベンゾピラン
誘導体またはその医薬上許容される塩を一種または二種
以上含有して成る発毛促進剤に関する。
Description: TECHNICAL FIELD The present invention relates to a hair growth promoting agent containing one or more benzopyran derivatives or pharmaceutically acceptable salts thereof having an excellent hair growth promoting effect.

本発明は、抗ガン剤による脱毛、円形脱毛症、分娩後
脱毛症や男性型脱毛症に対する医薬品または化粧品の分
野において利用される。さらに、ヒツジ、ミンク等の毛
および毛皮を必要とする分野においても、発毛促進剤と
して利用される。
INDUSTRIAL APPLICABILITY The present invention is used in the field of medicine or cosmetics for alopecia areata, alopecia areata, postpartum alopecia and androgenetic alopecia due to anticancer agents. Further, it is also used as a hair growth promoter in fields requiring hair and fur such as sheep and mink.

背景技術 脱毛症は先天性脱毛症と後天性脱毛症とに大別され
る。このうち後天的脱毛症は瘢痕や皮膚病変を伴うもの
と伴わないものに2大別される。さらに瘢痕や皮膚病変
を伴わない脱毛症は薬物による脱毛症外傷性脱毛症
栄養障害・代謝障害に伴う脱毛内分泌異常に伴う脱
毛休止期脱毛(高熱後脱毛・分娩後脱毛)男性型脱
毛症円形脱毛症の7つに分けられる。従来の養毛ない
し育毛剤は、このうちの男性型脱毛症のみを対象とした
ものが大部分を占めていた。
BACKGROUND ART Alopecia is roughly classified into congenital alopecia and acquired alopecia. Of these, acquired alopecia is broadly classified into those with scars and those without skin lesions. Furthermore, alopecia without scars and skin lesions is alopecia due to drugs, traumatic alopecia, alopecia due to malnutrition and metabolic disorders, and hair loss telogen due to endocrine abnormalities (hair loss after high fever, postpartum hair loss) androgenetic alopecia The disease is divided into seven. Most of the conventional hair restorer or hair restorer only targets male pattern baldness.

男性型脱毛症の生理学上の特徴は、まず男性ホルモン
の本体であるテストステロンが標的器官である毛包細胞
の中にある5α−レゼクターゼにより、より強力な男性
ホルモンである5α−ジヒドロテストステロン(以下、
5α−DHTと称す)に変換される。この5α−DHTは細胞
内受容体と結合し、核に働いて頭髪の毛球部の毛母細胞
の分裂を抑制し、毛の成長を妨げ、抜毛、脱毛を促進す
るものとされている。そのため男性型脱毛症に対して、
レゼクターゼ阻害作用もしくは、5α−DHTが受容体と
結合することを阻害する作用を有する抗男性ホルモン剤
が使用されている。そのような抗男性ホルモン剤として
は、オキセンドロン、酢酸クロルマジノン、11α−ヒド
ロキシプロゲステロン、4α−アンドロステン−3−オ
ン−17βカルボン酸、シプロテインアセテートなどがあ
る。しかしながら、これらの抗男性ホルモン剤はいずれ
もステロイドホルモンの誘導体であり、生体に投与され
たときは、それ自体もしくはその代謝産物がホルモン作
用を示すことから、長期に使用した場合、重篤な副作用
を示すことが多く、安全性の面から問題があった。この
点からステロイド骨格を持たない、フラボノイド類の5
α−レゼクターゼ阻害薬も見い出されたが、これらはい
ずれも男性型脱毛症にのみ適応され、そのメカニズムか
ら脱毛症の進行を止めるのみにとどまるものである。
The physiological characteristics of androgenetic alopecia are as follows. First, testosterone, the main body of the male hormone, is activated by 5α-reductase in the hair follicle cells, the target organ, and 5α-dihydrotestosterone (hereinafter, referred to as “the male hormone”).
5α-DHT). This 5α-DHT binds to an intracellular receptor and acts on the nucleus to suppress the division of hair cells in the hair bulb portion of the hair, prevent the growth of hair, and promote hair removal and hair loss. Therefore, for male pattern baldness,
Anti-androgens have been used which have a reductase inhibitory action or an action of inhibiting the binding of 5α-DHT to a receptor. Such antiandrogens include oxendrone, chlormadinone acetate, 11α-hydroxyprogesterone, 4α-androsten-3-one-17β carboxylic acid, cyproteinacetate and the like. However, all of these antiandrogens are derivatives of steroid hormones, and when administered to the living body, they or their metabolites exhibit hormonal effects. And there was a problem in terms of safety. From this point, 5 of flavonoids which do not have a steroid skeleton
Although α-reductase inhibitors have also been found, they are all adapted only to androgenetic alopecia and only stop the progression of alopecia by the mechanism.

一方、これらの薬物とは異なり、他の後天性脱毛症に
も適応できるものとして、皮膚血管作動性の増強効果を
持つ塩化カルプロニウム(以下MTBと称す)がある。し
かし、このMTBも単なる血流増加効果がみられるのみ
で、後述するC3Hマウスの発毛に対して促進効果はみら
れない。
On the other hand, unlike these drugs, carpronium chloride (hereinafter referred to as MTB) having an effect of enhancing cutaneous vasoactivity is applicable to other acquired alopecia. However, this MTB also has only a mere effect of increasing blood flow, and has no promoting effect on hair growth of C3H mice described below.

さらに最近では、降圧剤であるジアゾキシドに発毛促
進効果が認められている。しかしながら、その発毛促進
効果は少量使用では非常に弱く、その効果を得るために
大量使用すると過血糖等の副作用を生じるという問題が
あった。同じく血圧降下剤としての作用のあるミノキシ
ジールにも発毛促進効果が認められている。ミノキシジ
ールは従来の薬物と異なり、前記のMTBが持つ血管拡張
作用のみならず、直接に毛包刺激作用が認められている
薬物である。したがって上記の抗男性ホルモン剤と異な
り、男性型脱毛症のみならず円形脱毛症等にも有効であ
る。しかし、その作用はミノキシジールが体内で硫酸化
されなければ発現しないため、その代謝能の、個人差が
問題とされる。さらに、体内への経皮吸収率が高いので
副作用としての降圧効果も懸念される共に、発毛促進効
果も充分ではない。
More recently, diazoxide, a hypotensive agent, has been shown to have a hair growth promoting effect. However, the effect of promoting hair growth is very weak when used in a small amount, and there is a problem that side effects such as hyperglycemia occur when used in a large amount in order to obtain the effect. Minoxidil, which also acts as a hypotensive agent, has also been shown to have a hair growth promoting effect. Minoxidil, unlike conventional drugs, is a drug that has not only the vasodilatory effect of the MTB but also a hair follicle stimulating effect. Therefore, unlike the above-mentioned antiandrogens, it is effective not only for male pattern baldness but also for alopecia areata. However, since its action is not expressed unless minoxidil is sulfated in the body, individual differences in its metabolic ability are problematic. Furthermore, since the transdermal absorption rate into the body is high, there is a concern about the antihypertensive effect as a side effect, and the hair growth promoting effect is not sufficient.

上述のジアゾキシドとミノキシジールのうち、ジアゾ
キシドは過血糖という問題点を持っており、ミノキシジ
ールは硫酸化されなければ活性化しないと共に発毛促進
効果が充分でない。したがって、過血糖という副作用を
持たずに、体内代謝を受けて活性化される必要がなく、
より強力な発毛促進効果があり、経皮吸収の低い薬物の
開発が望まれていた。
Among the above-mentioned diazoxides and minoxidil, diazoxide has a problem of hyperglycemia, and minoxidil is not activated unless it is sulfated, and its hair growth promoting effect is not sufficient. Therefore, without the side effect of hyperglycemia, there is no need to be activated by metabolism in the body,
It has been desired to develop a drug having a stronger hair growth promoting effect and a low transdermal absorption.

かかる現況において、本発明者らは、上記課題を解決
すべく鋭意研究を重ねた結果、ベンゾピラン誘導体のな
かに優れた効果を有する物質が存在することを見い出
し、この知見に基づいて本発明を完成した。
Under these circumstances, the present inventors have conducted intensive studies to solve the above-mentioned problems, and as a result, have found that there is a substance having an excellent effect among benzopyran derivatives, and completed the present invention based on this finding. did.

なお、国際出願公開WO90/14346号公報(国際出願日19
90年5月15日;国際公開日1990年11月29日)には、本発
明に用いられるベンゾピラン誘導体を包含する化合物が
記載されている。上記明細書等には、当該化合物が平滑
筋弛緩作用を有し、そのため呼吸障害や高血圧、胃腸れ
ん縮、心臓血管障害、てんかん等の治療に有効である旨
の記載がなされているが、発毛促進作用を有し、発毛促
進剤として効果がある旨の記載も示唆もなされていな
い。
In addition, International Application Publication No. WO90 / 14346 (International filing date 19
(May 15, 1990; International Publication Date November 29, 1990) describe compounds including benzopyran derivatives used in the present invention. The above specification states that the compound has a smooth muscle relaxing action and is therefore effective in treating respiratory disorders, hypertension, gastrointestinal spasm, cardiovascular disorders, epilepsy, etc. It does not mention or suggest that it has a hair promoting action and is effective as a hair growth promoting agent.

図面の簡単な説明 図1、3および5〜19は、ベンゾピラン誘導体等を塗
布投与したときのマウスの発毛効果を示すグラフであ
る。
BRIEF DESCRIPTION OF THE DRAWINGS FIGS. 1, 3 and 5 to 19 are graphs showing the hair growth effect of mice when a benzopyran derivative or the like is applied and applied.

図2および4は、試験開始から14日経過後のマウスの
発毛状況を示す写真である。
2 and 4 are photographs showing the hair growth status of mice 14 days after the start of the test.

発明を実施するための最良の形態 本発明の発毛促進剤は、下記の一般式(I)で表され
るベンゾピラン誘導体またはその医薬上許容される塩を
一種または二種以上含有することを特徴のする。
BEST MODE FOR CARRYING OUT THE INVENTION The hair growth-promoting agent of the present invention contains one or more benzopyran derivatives represented by the following general formula (I) or a pharmaceutically acceptable salt thereof. Do

上式において、Xは=O,=S,=N−Z又は=CHNO2
示し、ここでZは水素原子、低級アルキル基、アリール
基、水酸基、低級アルコキシ基、シアノ基、カルバモイ
ル基又はスルファモイル基を示す; Yは−NR8R9、−OR10又は−SR11を、ここでR8及びR9
は同一又は異なって水素原子、水酸基、低級アルコキシ
基、シアノ基、置換基を有していてもよいアミノ基、置
換基を有していてもよい低級アルキル基、置換基を有し
ていてもよい不飽和低級アルキル基、置換基を有してい
てもよいシクロアルキル基、置換基を有していてもよい
アリール基、置換基を有していてもよいヘテロアリール
基を示すか、又はR8及びR9は一緒になって窒素原子と共
に、置換基を有していてもよい復素環を示し、R10及びR
11は水素原子、低級アルキル基又はアリール基を示す; R1は水素原子、低級アルキル基又はアリール基を示す
か、又はR2と直接結合して単結合を形成する: R2及びR3は同一又は異なって水素原子若しくは水酸基を
示すか、又は一緒になって=Oを形成するか、あるいは
R2はR1と直接結合して単結合を形成する; R4及びR5は、同一又は異なって水素原子、置換基を有し
ていてもよい低級アルキル基を示すか、一緒になってポ
リメチレン基を示す; R6及びR7は、同一又は異なって水素原子、低級アルキル
基、低級ハロアルキル基、ハロゲン原子、低級アルコキ
シ基、低級ハロアルコキシ基、アミノ基、アシルアミノ
基、ニトロ基、シアノ基、エステル基、低級アルキルス
ルホニル基又はアリールスルホニル基を示すか、又は一
緒になって=N−O−N=を示す。
In the above formula, X represents OO, SS, NNZ or CHCHNO 2 , wherein Z is a hydrogen atom, a lower alkyl group, an aryl group, a hydroxyl group, a lower alkoxy group, a cyano group, a carbamoyl group or a sulfamoyl. Y represents —NR 8 R 9 , —OR 10 or —SR 11 , wherein R 8 and R 9
May be the same or different and include a hydrogen atom, a hydroxyl group, a lower alkoxy group, a cyano group, an amino group which may have a substituent, a lower alkyl group which may have a substituent, A good unsaturated lower alkyl group, a cycloalkyl group optionally having substituent (s), an aryl group optionally having substituent (s), a heteroaryl group optionally having substituent (s), or R 8 and R 9 together with a nitrogen atom represent an optionally substituted substituent, R 10 and R 9
11 is a hydrogen atom, a lower alkyl group or an aryl group; R 1 is a hydrogen atom, or a lower alkyl group or an aryl group, or forms a single bond directly bonded to the R 2: R 2 and R 3 The same or different and represent a hydrogen atom or a hydroxyl group, or together form = O, or
R 2 is directly bonded to R 1 to form a single bond; R 4 and R 5 are the same or different and represent a hydrogen atom, a lower alkyl group which may have a substituent, or taken together; R 6 and R 7 are the same or different and represent a hydrogen atom, a lower alkyl group, a lower haloalkyl group, a halogen atom, a lower alkoxy group, a lower haloalkoxy group, an amino group, an acylamino group, a nitro group, a cyano group , An ester group, a lower alkylsulfonyl group or an arylsulfonyl group, or together show = N-ON-.

一般式(I)で示される化合物の定義において、低級
アルキル基とは炭素数1〜6のアルキル基を意味し、好
ましくは炭素数1〜4のアルキル基である。このような
低級アルキル基の例としては、メチル基、エチル基、n
−プロピル基、i−プロピル基、n−ブチル基、i−ブ
チル基、s−ブチル基、t−ブチル基などが挙げられ
る。
In the definition of the compound represented by the formula (I), the lower alkyl group means an alkyl group having 1 to 6 carbon atoms, and preferably an alkyl group having 1 to 4 carbon atoms. Examples of such lower alkyl groups include methyl, ethyl, n
-Propyl group, i-propyl group, n-butyl group, i-butyl group, s-butyl group, t-butyl group and the like.

アリール基とは、芳香属炭化水素から水素原子1個を
除いた1価の置換基を意味し、具体的には、フェニル
基、トリル基、キシリル基、ビフェニル基、ナフチル
基、アントリル基、フェナントリル基などである。特に
好ましいのはフェニル基である。またアリール基の環上
の炭素原子はハロゲン原子、低級アルキル基、アミノ
基、ニトロ基、トリフルオロメチル基などの1種以上の
基によって置換されていてもよい。ヘテロアリール基と
は、ヘテロ原子を含有するアリール基で、具体的にはピ
リジン基、ピリミジニル基、チアゾリル基、オキサゾリ
ル基、イミダゾリル基、チアジアゾール基、テトラゾリ
ル基などである。また、これらの環上に置換基を有して
いてもよい。
The aryl group means a monovalent substituent obtained by removing one hydrogen atom from an aromatic hydrocarbon, and specifically includes a phenyl group, a tolyl group, a xylyl group, a biphenyl group, a naphthyl group, an anthryl group, and a phenanthryl. And the like. Particularly preferred is a phenyl group. The carbon atom on the ring of the aryl group may be substituted by one or more groups such as a halogen atom, a lower alkyl group, an amino group, a nitro group and a trifluoromethyl group. The heteroaryl group is an aryl group containing a hetero atom, and specific examples include a pyridine group, a pyrimidinyl group, a thiazolyl group, an oxazolyl group, an imidazolyl group, a thiadiazole group, and a tetrazolyl group. Further, these rings may have a substituent.

低級アルコキシ基とは、炭素数1〜6のアルコキシ基
を意味し、好ましくは炭素数1〜4のアルコキシ基であ
る。このような低級アルコキシ基の例としては、メトキ
シ基、エトキシ基、n−プロポキシ基、i−プロポキシ
基、n−ブトキシ基、i−ブトキシ基、s−ブトキシ
基、t−ブトキシ基などが挙げられる。
The lower alkoxy group means an alkoxy group having 1 to 6 carbon atoms, preferably an alkoxy group having 1 to 4 carbon atoms. Examples of such lower alkoxy groups include methoxy, ethoxy, n-propoxy, i-propoxy, n-butoxy, i-butoxy, s-butoxy, t-butoxy and the like. .

ハロゲン原子とは、塩素、臭素、フッ素、ヨウ素を意
味し、特に好ましいのは塩素である。
Halogen atom means chlorine, bromine, fluorine and iodine, and chlorine is particularly preferable.

シクロアルキル基とは、炭素3〜8のものが好まし
く、例えばシクロプロピル基、シクロブチル基、シクロ
ペンチル基、シクロヘキシル基等が挙げられる。
The cycloalkyl group preferably has 3 to 8 carbon atoms, and examples thereof include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, and a cyclohexyl group.

窒素含有複素環とは、例えばアジリジニル基、アゼチ
ジニル基、ピロリジニル基、ピペリジニル基、ピペラジ
ル基、モルホリノ基等が挙げられる。
Examples of the nitrogen-containing heterocycle include an aziridinyl group, an azetidinyl group, a pyrrolidinyl group, a piperidinyl group, a piperazyl group, and a morpholino group.

また置換基としてはハロゲン原子、低級アルキル基、
低級アルコキシ基、アミノ基、ニトロ基、低級ハロアル
キル基、低級ハロアルコキシ基、シアノ基等が挙げられ
る。
As the substituent, a halogen atom, a lower alkyl group,
Examples include a lower alkoxy group, an amino group, a nitro group, a lower haloalkyl group, a lower haloalkoxy group, and a cyano group.

一般式(I)で示される化合物は、例えば以下の様に
して製造することができる。
The compound represented by the general formula (I) can be produced, for example, as follows.

一般式(II) 〔式中、R4、R5、R6およびR7は前記と同じ意味を示す;R
12は水素原子、低級アルキル基又はアリール基を示す〕 で表されるベンゾピラン系化合物に、一般式(III) 〔式中、XおよびYは前記と同じ意味を示す;Lはハロゲ
ン原子、−OR13、−S(O)nR14等の脱離基を示し、こ
こで、R13およびR14は水素原子、低級アルキル基または
アリール基を、nは0〜2の整数を示す〕 で表される化合物を塩基の存在下、不活性溶媒中で反応
させることによって得られる。
General formula (II) Wherein R 4 , R 5 , R 6 and R 7 have the same meaning as described above;
12 represents a hydrogen atom, a lower alkyl group or an aryl group.] A benzopyran-based compound represented by the general formula (III) Wherein X and Y have the same meanings as described above; L represents a leaving group such as a halogen atom, —OR 13 , —S (O) n R 14 , wherein R 13 and R 14 are hydrogen Atom, lower alkyl group or aryl group, n represents an integer of 0 to 2] in the presence of a base in an inert solvent.

ここに用いる塩基としては、例えば水素化ナトリウ
ム、ナトリウムアルコキシド、カリウムアルコキシド、
アルキルリチウム、炭酸カリウム、炭酸ナトリウム、水
酸化カリウムまたは水酸化ナトリウム等があげられる。
As the base used here, for example, sodium hydride, sodium alkoxide, potassium alkoxide,
Examples thereof include alkyl lithium, potassium carbonate, sodium carbonate, potassium hydroxide and sodium hydroxide.

また、前記一般式(I)の本発明化合物は、前記一般
式(II)で示される化合物に、一般式(IV) X=C=W (IV) (式中、Xは前記と同じ意味を表し;Wは酸素原子、イオ
ウ原子またはN−R15を示し、ここでR15は、水素原子、
水酸基、低級アルコキシ基、シアノ基、置換基を有して
いてもよいアミノ基、置換基を有していてもよい低級ア
ルキル基、置換基を有していてもよい不飽和低級アルキ
ル基、置換基を有していてもよいシクロアルキル基、置
換基を有していてもよいアリール基、置換基を有してい
てもよいヘテロアリール基を示す)で表される化合物を
反応させて得ることもできる。上記一般式(IV)で表さ
れる化合物としては、例えばメチルイソチオシアネート
等があげられる。
In addition, the compound of the present invention represented by the general formula (I) can be obtained by adding a compound represented by the general formula (II) to a general formula (IV) X = C = W (IV) (where X has the same meaning as described above) It represents; W is an oxygen atom, a sulfur atom or N-R 15, wherein R 15 is a hydrogen atom,
Hydroxyl group, lower alkoxy group, cyano group, amino group which may have a substituent, lower alkyl group which may have a substituent, unsaturated lower alkyl group which may have a substituent, A cycloalkyl group which may have a group, an aryl group which may have a substituent, and a heteroaryl group which may have a substituent). Can also. Examples of the compound represented by the general formula (IV) include methyl isothiocyanate.

前記一般式(I)の化合物はまた、一般式(V) (式中、X、Y、R4、R5、R6、R7およびR12は前記と同
じ意味を示す)で表される化合物を還元することによっ
て、また、一般式(VI) (式中、X、Y、R4、R5、R6およびR7は前記と同じ意味
を示す)で表される化合物を脱水することによって、ま
た、さらに生成した3、4位の二重結合を還元すること
によっても得られる。
The compound of the general formula (I) may also have the general formula (V) (Wherein X, Y, R 4 , R 5 , R 6 , R 7 and R 12 have the same meanings as described above), by reducing the compound represented by the general formula (VI) (Wherein X, Y, R 4 , R 5 , R 6 and R 7 have the same meanings as described above). It can also be obtained by reducing the bond.

還元反応は不活性溶媒中、還元剤例えば、NaBH4、KBH
4、LiBH4、NaBH3CN、LiAlH4等の水素化ホウ素あるいは
金属水素化物を作用させるか、またはパラジウム炭素や
ラネーニッケル等を用いる接触還元によって行うことが
できる。
The reduction reaction is carried out in an inert solvent in a reducing agent such as NaBH 4 , KBH
4 , borohydride or metal hydride such as LiBH 4 , NaBH 3 CN, LiAlH 4 or the like, or catalytic reduction using palladium carbon, Raney nickel or the like.

脱水反応は、不活性溶媒中、パラトルエンスルホン
酸、塩化水素などの酸を用いるか、または塩基の存在
下、パラトルエンスルホニルクロライドやアセチルクロ
ライド等の酸ハロゲン化物あるいは無水酢酸等の酸無水
物を用いることによって行われる。ここで用いられる塩
基としては、ピリジン、トリエチルアミン等の有機塩基
または、水素化ナトリウム、ナトリウムアルコキシド、
カリウムアルコキシド、アルキルリチウム、炭酸カリウ
ム、炭酸ナトリウム、水酸化カリウム、水酸化ナトリウ
ム等が挙げられる。
The dehydration reaction uses an acid such as paratoluenesulfonic acid or hydrogen chloride in an inert solvent, or an acid halide such as paratoluenesulfonyl chloride or acetyl chloride or an acid anhydride such as acetic anhydride in the presence of a base. It is done by using. As the base used here, pyridine, an organic base such as triethylamine, or sodium hydride, sodium alkoxide,
Examples include potassium alkoxide, alkyl lithium, potassium carbonate, sodium carbonate, potassium hydroxide, sodium hydroxide and the like.

また、本発明化合物(I)は実施例に記載される具体
的な製造法を応用して得ることもできる。
Further, the compound (I) of the present invention can also be obtained by applying a specific production method described in Examples.

ベンゾピラン誘導体の配合量は、本発明の発毛促進剤
中0.001〜10重量%(以下、重量%は単に%と記す)程
度である。0.001%未満では発毛促進効果が発揮できな
い場合がある。また、配合量が多いほど養毛効果が大き
いが、多量に用いられた時の副作用の発現などを考慮し
て10%以下が好ましい。より好適には、0.01〜5%であ
る。
The blending amount of the benzopyran derivative is about 0.001 to 10% by weight (hereinafter, the weight% is simply referred to as%) in the hair growth promoter of the present invention. If it is less than 0.001%, the effect of promoting hair growth may not be exhibited. Also, the greater the blending amount, the greater the hair-growing effect, but it is preferably 10% or less in consideration of the appearance of side effects when used in large amounts. More preferably, it is 0.01 to 5%.

本発明に係る発毛促進剤は上記のベンゾピラン誘導体
の他に、一般に養毛剤に使用されるサリチル酸やレゾル
シン及びヘキサクロロフェンのような殺菌剤や、ニコチ
ン酸、ビタミンE、ビタミンA類、パントテン酸、ビオ
チンその他のビタミン類、脂肪酸類、アミノ酸類、メン
トール、エタノールのような低級アルコール、セタノー
ルのような高級アルコール、ポリエチレングリコール、
プロピレングリコールのような多価アルコール、ヒドロ
キシプロピルセルロースのようなセルロース類、動物
性、植物性及び合成油脂性成分、ワセリン、ロウ、シリ
コン、界面活性剤、酸化亜鉛等の希釈剤、さらには保湿
剤、増粘剤、懸濁剤、防腐剤、酸化防止剤、香料、色剤
等を配合することができる。
In addition to the above-mentioned benzopyran derivative, the hair growth promoting agent according to the present invention includes a fungicide such as salicylic acid, resorcin and hexachlorophene, which is generally used for a hair restorer, nicotinic acid, vitamin E, vitamin A, pantothenic acid, biotin Other vitamins, fatty acids, amino acids, menthol, lower alcohols such as ethanol, higher alcohols such as cetanol, polyethylene glycol,
Polyhydric alcohols such as propylene glycol, celluloses such as hydroxypropylcellulose, animal, vegetable and synthetic fats and oils, petrolatum, wax, silicone, surfactants, diluents such as zinc oxide, and humectants , A thickener, a suspending agent, a preservative, an antioxidant, a fragrance, a coloring agent and the like.

本発明に係る発毛促進剤は、液状、乳液、軟膏、クリ
ーム、ゲル、エアゾールなど外用として用いられるどの
ような剤形にも適応でき、また、シャンプーやリンスな
どにも適用することができる。
The hair growth promoter according to the present invention can be applied to any externally used dosage form such as liquid, emulsion, ointment, cream, gel, aerosol, and can be applied to shampoo and rinse.

以下に製造例および実施例を記載して、本発明をさら
に具体的に説明する。ただし、これらの製造例および実
施例は本発明の範囲を制限するものではない。
Hereinafter, the present invention will be described more specifically with reference to Production Examples and Examples. However, these production examples and examples do not limit the scope of the present invention.

製造例1〜42は、下記の表1に記載されるベンゾピラ
ン誘導体の製造方法を説明するものである。
Production Examples 1-42 illustrate the methods for producing the benzopyran derivatives described in Table 1 below.

製造例1 N−メチル−6−シアノ−3−ヒドロキシ−2,2−ジメ
チル−2H−1−ベンゾピラン−4−カルボチオアミド 6−シアノ−3,4−ジヒドロ−2,2−ジメチル−2H−1
−ベンゾピラン−3−オン1.5g、メチルイソチオシアネ
ート0.6gおよび乾燥N,N−ジメチルホルムアミド15mの
混合物に、氷冷攪拌下、カリウム第三ブトキシド0.93g
を加え、氷冷下4時間攪拌した。氷水を加え酢酸酸性に
し、エーテルで抽出し、エーテル層を水洗後、硫酸ナト
リウムで乾燥した。エーテル層を留去後、残渣をエタノ
ールから再結晶し、融点186〜187℃の下記式で表される
N−メチル−6−シアノ−3−ヒドロキシ−2,2−ジメ
チル−2H−1−ベンゾピラン−4−カルボチオアミド1.
4gを得た。
Production Example 1 N-methyl-6-cyano-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-carbothioamide 6-cyano-3,4-dihydro-2,2-dimethyl-2H-1
-To a mixture of 1.5 g of benzopyran-3-one, 0.6 g of methyl isothiocyanate and 15 m of dry N, N-dimethylformamide, 0.93 g of potassium tert-butoxide under ice-cooling and stirring
Was added and the mixture was stirred under ice cooling for 4 hours. Ice water was added to make the mixture acidic, and the mixture was extracted with ether. The ether layer was washed with water and dried over sodium sulfate. After the ether layer was distilled off, the residue was recrystallized from ethanol, and N-methyl-6-cyano-3-hydroxy-2,2-dimethyl-2H-1-benzopyran having a melting point of 186 to 187 ° C and represented by the following formula: -4-carbothioamide 1.
4 g were obtained.

NMR(CDCl3):1.5(6H,s),3.3(3H,d),7.0(1H,d),
7.4(1H,dd),7.5(1H,d),7.6(1H,br.s),13.5(1H,
s) MS:274(M+製造例2 シス−N−メチル−6−シアノ−3,4−ジヒドロ−3−
ヒドロキシ−2,2−ジメチル−2H−1−ベンゾピラン−
4−カルボチオアミド;および トランス−N−メチル−6−シアノ−3,4−ジヒドロ
−3−ヒドロキシ−2,2−ジメチル−2H−1−ベンゾピ
ラン−4−カルボチオアミド N−メチル−6−シアノ−3−ヒドロキシ−2,2−ジ
メチル−2H−1−ベンゾピラン−4−カルボチオアミド
1.4g、テトラヒドロフラン15mおよびメタノール15m
の混合物を−10℃で攪拌下、ナトリウムボロハイドライ
ド(NaBH4)0.23gを加え、−10℃下で2時間攪拌し、次
いで室温で2時間攪拌した。反応液を減圧留去し、氷水
を加え酢酸酸性とした後、エーテルおよび酢酸エチルで
抽出した。有機層を合し、Na2SO4で乾燥後、留去した。
残渣をシリカゲルクロマトグラフィー(展開液CH2Cl2:A
cOEt=2:1)に付し、最初に留出するフラクションから
融点170〜173℃の下記式で表されるシス−N−メチル−
6−シアノ−3,4−ジヒドロ−3−ヒドロキシ−2,2−ジ
メチル−2H−1−ベンゾピラン−4−カルボチオアミド
0.1gを得た。
NMR (CDCl 3 ): 1.5 (6H, s), 3.3 (3H, d), 7.0 (1H, d),
7.4 (1H, dd), 7.5 (1H, d), 7.6 (1H, br.s), 13.5 (1H,
s) MS: 274 (M + ). Production Example 2 cis-N-methyl-6-cyano-3,4-dihydro-3-
Hydroxy-2,2-dimethyl-2H-1-benzopyran-
4-carbothioamide; and trans-N-methyl-6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-carbothioamide N-methyl-6-cyano- 3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-carbothioamide
1.4 g, tetrahydrofuran 15 m and methanol 15 m
Was added to sodium borohydride (NaBH 4 ) (0.23 g) under stirring at −10 ° C., followed by stirring at −10 ° C. for 2 hours and then at room temperature for 2 hours. The reaction solution was distilled off under reduced pressure, and made acidic with acetic acid by adding ice water, and then extracted with ether and ethyl acetate. The organic layers were combined, dried over Na 2 SO 4 and evaporated.
The residue is subjected to silica gel chromatography (developing solution CH 2 Cl 2 : A
cOEt = 2: 1), and cis-N-methyl- having a melting point of 170-173 ° C.
6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-carbothioamide
0.1 g was obtained.

NMR(CDCl3):1.3(3H,s),1.5(3H,s),3.25(3H,d),
4.1(1H,d),4.5(1H,d),6.9(1H,d),7.4(2H),8.4
(1H,br.s)。
NMR (CDCl 3 ): 1.3 (3H, s), 1.5 (3H, s), 3.25 (3H, d),
4.1 (1H, d), 4.5 (1H, d), 6.9 (1H, d), 7.4 (2H), 8.4
(1H, br.s).

MS:276(M+) 次いで、留出するフラクションから融点213〜214℃の
下記式で表されるトランス−N−メチル−6−シアノ−
3,4−ジヒドロ−3−ヒドロキシ−2,2−ジメチル−2H−
1−ベンゾピラン−4−カルボチオアミド0.1gを得た。
MS: 276 (M + ) Then, trans-N-methyl-6-cyano- represented by the following formula having a melting point of 213 to 214 ° C from the distilled fraction:
3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-
0.1 g of 1-benzopyran-4-carbothioamide was obtained.

NMR(CDCl3):1.2(3H,s),1.5(3H,s),3.25(3H,d),
3.5(1H,br.s),4.0(1H,d),4.25(1H,d),6.9(1H,
d),7.4(2H),8.3(1H,br.s) MS:276(M+製造例3 N−メチル−6−シアノ−2,2−ジメチル−2H−1−
ベンゾピラン−4−カルボチオアミド N−メチル−6−シアノ−3,4−ジヒドロ−3−ヒド
ロキシ−2,2−ジメチル−2H−1−ベンゾピラン−4−
カルボチオアミド0.44g、パラトルエンスルホン酸1水
和物0.07gおよびトルエン30mの混合物を10時間加熱還
流した。溶媒を留去し、残渣をシリカゲルクロマトグラ
フィー(展開液CH2Cl2)で精製して、融点139〜141℃の
下記式で表されるN−メチル−6−シアノ−2,2−ジメ
チル−2H−1−ベンゾピラン−4−カルボチオアミド0.
18gを得た。
NMR (CDCl 3 ): 1.2 (3H, s), 1.5 (3H, s), 3.25 (3H, d),
3.5 (1H, br.s), 4.0 (1H, d), 4.25 (1H, d), 6.9 (1H,
d), 7.4 (2H), 8.3 (1H, br.s) MS: 276 (M + ) Production Example 3 N-methyl-6-cyano-2,2-dimethyl-2H-1-
Benzopyran-4-carbothioamide N-methyl-6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-
A mixture of 0.44 g of carbothioamide, 0.07 g of paratoluenesulfonic acid monohydrate and 30 m of toluene was heated under reflux for 10 hours. The solvent was distilled off, and the residue was purified by silica gel chromatography (developing solution: CH 2 Cl 2 ) to give N-methyl-6-cyano-2,2-dimethyl- having a melting point of 139 to 141 ° C. and represented by the following formula. 2H-1-benzopyran-4-carbothioamide 0.
18 g were obtained.

NMR(CDCl3):1.5(6H,s),3.25(3H,d),5.8(1H,s),
6.8(1H,d),7.4(1H,dd),7.7(1H,d),7.8(1H,br.
s) MS:258(M+製造例4 6−シアノ−3−ヒドロキシ−2,2−ジメチル−2H−1
−ベンゾピラン−4−ジチオカルボン酸メチルエステル 6−シアノ−3,4−ジヒドロ−2,2−ジメチル−2H−1
−ベンゾピラン−3−オン2.0g、二硫化炭素2.3gおよび
乾燥N,N−ジメチルホルムアミド20mの混合物に、氷冷
攪拌下、カリウム第三ブトキシド1.3gを加え、30分間攪
拌後、ヨー化メチル1.56gおよび乾燥N,N−ジメチルホル
ムアミド8mの混合物を滴下し、氷冷下1時間攪拌し
た。氷水を加えエーテルで抽出し、エーテル層を水洗
後、硫酸ナトリウムで乾燥した。エーテル層を留去後、
残渣をシリカゲルクロマトグラフィー(展開液CH2Cl2
で精製して黄色油状物質として下記式で示される6−シ
アノ−3−ヒドロキシ−2,2−ジメチル−2H−1−ベン
ゾピラン−4−ジチオカルボン酸メチルエステル1.2gを
得た。
NMR (CDCl 3 ): 1.5 (6H, s), 3.25 (3H, d), 5.8 (1H, s),
6.8 (1H, d), 7.4 (1H, dd), 7.7 (1H, d), 7.8 (1H, br.
s) MS: 258 (M + ). Production Example 4 6-cyano-3-hydroxy-2,2-dimethyl-2H-1
-Benzopyran-4-dithiocarboxylic acid methyl ester 6-cyano-3,4-dihydro-2,2-dimethyl-2H-1
To a mixture of 2.0 g of benzopyran-3-one, 2.3 g of carbon disulfide and 20 m of dry N, N-dimethylformamide, 1.3 g of potassium tert-butoxide was added under ice-cooling and stirring, and after stirring for 30 minutes, methyl iodide 1.56 g and dry N, N-dimethylformamide (8 m) were added dropwise, and the mixture was stirred for 1 hour under ice cooling. Ice water was added, and the mixture was extracted with ether. The ether layer was washed with water and dried over sodium sulfate. After distilling off the ether layer,
Silica gel chromatography of the residue (developing solution CH 2 Cl 2 )
To give 1.2 g of 6-cyano-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-dithiocarboxylic acid methyl ester represented by the following formula as a yellow oily substance.

NMR(CDCl3):1.5(6H,s),2.7(3H,s),7.0(1H,d),
7.45(1H,dd),8.15(1H,d),14.65(1H,s) MS:291(M+製造例5 N−フェニル−6−シアノ−3−ヒドロキシ−2,2−ジ
メチル−2H−1−ベンゾピラン−4−カルボチオアミド 6−シアノ−3,4−ジヒドロ−2,2−ジメチル−2H−1
−ベンゾピラン−3−オン0.5g、フェニルイソチオシア
ネート0.37gおよび乾燥N,N−ジメチルホルムアミド5m
の混合物に、氷冷攪拌下、カリウム第三ブトキシド0.31
gを加え、氷冷下5時間攪拌した。氷水を加え、酢酸酸
性にし、エーテルで抽出した。エーテル層を水洗後硫酸
ナトリウムで乾燥し、エーテルを留去した。残渣をシリ
カゲルクロマトグラフィー(展開液CH2Cl2)で精製し、
融点300℃以上(140℃付近で軟化後固化)の下記式で表
わされるN−フェニル−6−シアノ−3−ヒドロキシ−
2,2−ジメチル−2H−1−ベンゾピラン−4−カルボチ
オアミド0.4gを得た。
NMR (CDCl 3 ): 1.5 (6H, s), 2.7 (3H, s), 7.0 (1H, d),
7.45 (1H, dd), 8.15 (1H, d), 14.65 (1H, s) MS: 291 (M + ) Production Example 5 N-phenyl-6-cyano-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-carbothioamide 6-cyano-3,4-dihydro-2,2-dimethyl-2H-1
0.5 g of benzopyran-3-one, 0.37 g of phenylisothiocyanate and 5 m of dry N, N-dimethylformamide
To a mixture of potassium tert-butoxide 0.31 under ice-cooling and stirring.
g was added and the mixture was stirred for 5 hours under ice cooling. Ice water was added, the mixture was acidified with acetic acid, and extracted with ether. The ether layer was washed with water and dried over sodium sulfate, and the ether was distilled off. The residue was purified by silica gel chromatography (developing solution CH 2 Cl 2 ),
N-phenyl-6-cyano-3-hydroxy- represented by the following formula having a melting point of 300 ° C. or more (solidified after softening at around 140 ° C.)
0.4 g of 2,2-dimethyl-2H-1-benzopyran-4-carbothioamide was obtained.

NMR(CDCl3):1.5(6H,s),7.0(1H,d),7.25−7.65(7
H),8.75(1H,br.s),13.55(1H,br,s) MS:336(M+製造例6 N−フェニル−6−シアノ−3−ヒドロキシ−2,2−ジ
メチル−2H−1−ベンゾピラン−4−カルボキシアミド 6−シアノ−3,4−ジヒドロ−2,2−ジメチル−2H−1
−ベンゾピラン−3−オン0.5g、カリウム第三ブトキシ
ド0.39gおよび乾燥N,N−ジメチルホルムアミド5mの混
合物に、氷冷攪拌下、フェニルイソシアネート0.42gと
乾燥N,N−ジメチルホルムアミド1.5mの混合物を滴下
した。氷冷下4時間攪拌し、氷水を加え酢酸酸性とし、
エーテルで抽出した。エーテル層を水洗後硫酸ナトリウ
ムで乾燥し、エーテルを留去した。残渣をシリカゲルク
ロマトグラフィー(展開液CH2Cl2)で精製し、融点167
〜170℃の下記式で示されるN−フェニル−6−シアノ
−3−ヒドロキシ−2,2−ジメチル−2H−1−ベンゾピ
ラン−4−カルボキシアミド0.17gを得た。
NMR (CDCl 3): 1.5 ( 6H, s), 7.0 (1H, d), 7.25-7.65 (7
H), 8.75 (1H, br.s), 13.55 (1H, br, s) MS: 336 (M + ) Production Example 6 N-phenyl-6-cyano-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-carboxamide 6-cyano-3,4-dihydro-2,2-dimethyl-2H-1
To a mixture of 0.5 g of benzopyran-3-one, 0.39 g of potassium tert-butoxide and 5 m of dry N, N-dimethylformamide, a mixture of 0.42 g of phenylisocyanate and 1.5 m of dry N, N-dimethylformamide was stirred under ice-cooling. It was dropped. Stir for 4 hours under ice-cooling, add ice water to acidify acetic acid,
Extracted with ether. The ether layer was washed with water and dried over sodium sulfate, and the ether was distilled off. The residue was purified by silica gel chromatography (developing solution: CH 2 Cl 2 ).
0.17 g of N-phenyl-6-cyano-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-carboxamide represented by the following formula at ~ 170 ° C was obtained.

NMR(CDCl3):1.5(6H,s),7.05(1H,d),7.25−7.75
(8H),14.1(1H,s). MS:320(M+製造例7 N,2−ジメチル−6−シアノ−2−エチル−2H−1−ベ
ンゾピラン−4−カルボチオアミド N,2−ジメチル−6−シアノ−2−エチル−3−ヒド
ロキシ−2H−1−ベンゾピラン−4−カルボチオアミド
0.8g、およびメタノール20mの混合物に、氷冷攪拌
下、ナトリウムボロハイドライド(NaBH4)0.24gを加
え、室温で2時間攪拌した。反応液を減圧留去し、水を
加えエーテルで抽出した。有機層を水洗乾燥後、溶媒を
留去すると0.43gのN,2−ジメチル−6−シアノ−3,4−
ジヒドロ−2−エチル−3−ヒドロキシ−2H−1−ベン
ゾピラン−4−カルボチオアミドを得た。次いで、これ
にパラトルエンスルホン酸1水和物0.1gおよびトルエン
30mを加え3時間加熱還流した後溶媒を留去した。残
渣をシリカゲルクロマトグラフィー(展開液CH2Cl2)で
精製して、融点139〜141℃の下記式で表されるN,2−ジ
メチル−6−シアノ−2−エチル−2H−1−ベンゾピラ
ン−4−カルボチオアミド0.2gを得た。
NMR (CDCl 3): 1.5 ( 6H, s), 7.05 (1H, d), 7.25-7.75
(8H), 14.1 (1H, s). MS: 320 (M + ) Production Example 7 N, 2-dimethyl-6-cyano-2-ethyl-2H-1-benzopyran-4-carbothioamide N, 2-dimethyl-6-cyano-2-ethyl-3-hydroxy-2H-1-benzopyran -4-carbothioamide
To a mixture of 0.8 g and 20 m of methanol, 0.24 g of sodium borohydride (NaBH 4 ) was added under ice-cooling and stirring, followed by stirring at room temperature for 2 hours. The reaction solution was evaporated under reduced pressure, water was added, and the mixture was extracted with ether. After the organic layer was washed with water and dried, the solvent was distilled off to obtain 0.43 g of N, 2-dimethyl-6-cyano-3,4-.
Dihydro-2-ethyl-3-hydroxy-2H-1-benzopyran-4-carbothioamide was obtained. Next, 0.1 g of paratoluenesulfonic acid monohydrate and toluene
After adding 30 m and heating under reflux for 3 hours, the solvent was distilled off. The residue was purified by silica gel chromatography (developing solution: CH 2 Cl 2 ), and N, 2-dimethyl-6-cyano-2-ethyl-2H-1-benzopyran- represented by the following formula having a melting point of 139 to 141 ° C. 0.2 g of 4-carbothioamide was obtained.

NMR(CDCl3):1.0(3H,t),1.45(3H,s),1.75(2H,
m),3.3(3H,d),5.8(1H,s),6.85(1H,d),7.4(1H,d
d),7.7(1H,d),7.8(1H,br.s) 製造例8 N,2,2−トリメチル−6−ニトロ−2H−1−ベンゾピラ
ン−4−カルボチオアミド N,2,2−トリメチル−3,4−ジヒドロ−3−ヒドロキシ
−6−ニトロ−2H−1−ベンゾピラン−4−カルボチオ
アミド7.0g、パラトルエンスルホン酸1水和物3.0gおよ
びトルエン300mの混合物を、1時間加熱還流した。溶
媒を留去し、残渣をシリカゲルクロマトグラフィー(展
開液CH2Cl2)で精製し、CH2Cl2とエーテルとヘキサンの
混合溶媒から再結晶して融点147〜148℃の下記式で示さ
れるN,2,2−トリメチル−6−ニトロ−2H−1−ベンゾ
ピラン−4−カルボチオアミド3.25gを得た。
NMR (CDCl 3 ): 1.0 (3H, t), 1.45 (3H, s), 1.75 (2H,
m), 3.3 (3H, d), 5.8 (1H, s), 6.85 (1H, d), 7.4 (1H, d)
d), 7.7 (1H, d), 7.8 (1H, br.s) Production Example 8 N, 2,2-trimethyl-6-nitro-2H-1-benzopyran-4-carbothioamide N, 2,2-trimethyl-3,4-dihydro-3-hydroxy-6-nitro-2H-1 A mixture of -benzopyran-4-carbothioamide (7.0 g), paratoluenesulfonic acid monohydrate (3.0 g) and toluene (300 m) was heated to reflux for 1 hour. The solvent is distilled off, the residue is purified by silica gel chromatography (developing solution CH 2 Cl 2 ), and recrystallized from a mixed solvent of CH 2 Cl 2 , ether and hexane, and represented by the following formula having a melting point of 147 to 148 ° C. 3.25 g of N, 2,2-trimethyl-6-nitro-2H-1-benzopyran-4-carbothioamide were obtained.

NMR(CDCl3):1.5(6H,s),3.3(3H,d),5.9(1H,s),
6.85(1H,d),7.9(1H,br,s),8.0(1H,dd),8.3(1H,
d) MS:278(M+製造例9 N−エチル−6−シアノ−2,2−ジメチル−2H−1−ベ
ンゾピラン−4−カルボチオアミド N−エチル−6−シアノ−2,2−ジメチル−2H−1−
ベンゾピラン−4−カルボアミド0.14g、ローソン試薬
3.45gおよびベンゼン10mの混合物を、1時間還流し
た。不溶物を吸引濾過して除き、メチレンクロライドで
洗った後、母液と洗液を合し、溶媒を留去した。残渣を
シリカゲルクロマトグラフィー(展開液CH2Cl2)で精製
して、融点151〜153℃の下記式で表されるN−エチル−
6−シアノ−2,2−ジメチル−2H−1−ベンゾピラン−
4−カルボチオアミド0.12gを得た。
NMR (CDCl 3 ): 1.5 (6H, s), 3.3 (3H, d), 5.9 (1H, s),
6.85 (1H, d), 7.9 (1H, br, s), 8.0 (1H, dd), 8.3 (1H,
d) MS: 278 (M + ) Production Example 9 N-ethyl-6-cyano-2,2-dimethyl-2H-1-benzopyran-4-carbothioamide N-ethyl-6-cyano-2,2-dimethyl-2H-1-
Benzopyran-4-carbamide 0.14 g, Lawson's reagent
A mixture of 3.45 g and 10 m of benzene was refluxed for 1 hour. The insolubles were removed by suction filtration, washed with methylene chloride, the mother liquor and the washing were combined, and the solvent was distilled off. The residue was purified by silica gel chromatography (developing solution CH 2 Cl 2 ) to give N-ethyl- having a melting point of 151 to 153 ° C. and represented by the following formula.
6-cyano-2,2-dimethyl-2H-1-benzopyran-
0.12 g of 4-carbothioamide was obtained.

NMR(CDCl3):1.33(3H,t),1.49(6H,s),3.56−4.10
(2H,m),5.81(1H,s),6.85(1H,d),7.40(1H,dd),
7.75(1H,d),7.82(1H,br.s) MS:272(M+製造例10 N−メチル−6−ニトロ−2,2−ジメチル−2H−1−ベ
ンゾピラン−4−カルボアミド (1)6−ニトロ−3,4−ジヒドロ−2,2−ジメチル−2H
−1−ベンゾピラン−3−オン3.2g、メチルイソシアネ
ート1.2gおよび乾燥N,N−ジメチルホルムアミド40mの
混合物に、氷冷攪拌下、カリウム第三ブトキシド1.9gを
加え、氷冷下3時間攪拌し、さらに12時間放置した。氷
水を加え塩酸酸性にし、塩化メチレンで抽出した。有機
層を2N NaOHで再抽出した。水層を塩酸酸性とし、塩化
メチレンで再度抽出した。有機層を硫酸マグネシウムで
乾燥後、減圧濃縮し、残渣をシリカゲルカラムクロマト
グラフィ(展開液、n−ヘキサン:酢酸エチル=10:1)
に付し、さらに塩化メチレンとn−ヘキサンの混合液よ
り再結晶し、融点148−149℃のN−メチル−6−ニトロ
−3−ヒドロキシ−2,2−ジメチル−2H−1−ベンゾピ
ラン−4−カルボチオアミド2.33gを得た。
NMR (CDCl 3): 1.33 ( 3H, t), 1.49 (6H, s), 3.56-4.10
(2H, m), 5.81 (1H, s), 6.85 (1H, d), 7.40 (1H, dd),
7.75 (1H, d), 7.82 (1H, br.s) MS: 272 (M + ) Production Example 10 N-methyl-6-nitro-2,2-dimethyl-2H-1-benzopyran-4-carbamide (1) 6-nitro-3,4-dihydro-2,2-dimethyl-2H
To a mixture of 3.2 g of -1-benzopyran-3-one, 1.2 g of methyl isocyanate and 40 m of dry N, N-dimethylformamide, 1.9 g of potassium tert-butoxide was added with stirring under ice-cooling, followed by stirring for 3 hours under ice-cooling. It was left for another 12 hours. The mixture was acidified with hydrochloric acid by adding ice water, and extracted with methylene chloride. The organic layer was re-extracted with 2N NaOH. The aqueous layer was acidified with hydrochloric acid and extracted again with methylene chloride. The organic layer is dried over magnesium sulfate, concentrated under reduced pressure, and the residue is subjected to silica gel column chromatography (developing solution, n-hexane: ethyl acetate = 10: 1).
And recrystallized from a mixture of methylene chloride and n-hexane to give N-methyl-6-nitro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4 having a melting point of 148-149 ° C. -2.33 g of carbothioamide were obtained.

NMR(CDCl3):1.5(6H,s),3.25(3H,d),6.9(1H,d),
7.85(1H,dd),8.0(1H,d),7.4−8.2(1H,br),13.5
(1H,s). MS:294(M+) (2)N−メチル−6−ニトロ−3−ヒドロキシ−2,2
−ジメチル−2H−1−ベンゾピラン−4−カルボチオア
ミド2.08g、メタノール50mの混合物を−10℃で攪拌
下、水素化ホウ素ナトリウム1.33gを加え、−10℃から
室温までゆっくりと上昇させながら24時間攪拌した。反
応液を減圧濃縮し、残渣に水を加え塩化メチレンで抽出
した。有機層を飽和食塩水で洗浄後、硫酸マグネシウム
で乾燥し、減圧濃縮した。残渣を塩化メチレンとn−ヘ
キサンの混合液より再結晶し、融点203−207℃のN−メ
チル−6−ニトロ−3,4−ジヒドロ−3−ヒドロキシ−
2,2−ジメチル−2H−1−ベンゾピラン−4−カルボチ
オアミド0.6gを得た。
NMR (CDCl 3 ): 1.5 (6H, s), 3.25 (3H, d), 6.9 (1H, d),
7.85 (1H, dd), 8.0 (1H, d), 7.4-8.2 (1H, br), 13.5
(1H, s). MS: 294 (M <+> ) (2) N-methyl-6-nitro-3-hydroxy-2,2
A mixture of 2.08 g of dimethyl-2H-1-benzopyran-4-carbothioamide and 50 m of methanol was added at 1.3 ° C. with stirring at −10 ° C., and gradually increased from −10 ° C. to room temperature for 24 hours. Stirred. The reaction solution was concentrated under reduced pressure, water was added to the residue, and the mixture was extracted with methylene chloride. The organic layer was washed with saturated saline, dried over magnesium sulfate, and concentrated under reduced pressure. The residue was recrystallized from a mixture of methylene chloride and n-hexane to give N-methyl-6-nitro-3,4-dihydro-3-hydroxy- having a melting point of 203-207 ° C.
0.6 g of 2,2-dimethyl-2H-1-benzopyran-4-carbothioamide was obtained.

NMR(CDCl3、CF3CO2D):1.25(3H,s),1.55(3H,s),3.
3(3H,s),4.1(1H,d),4.35(1H,d),6.9(1H,d),7.9
(1H,d),8.1(1H,dd) MS:296(M+) (3)N−メチル−6−ニトロ−3,4−ジヒドロ−3−
ヒドロキシ−2,2−ジメチル−2H−1−ベンゾピラン−
4−カルボチオアミド0.42g、塩化p−トルエンスルフ
ォニル0.58gおよびピリジン30mの混合物を3時間加熱
還流した。反応液を濃縮し2N塩酸を加えジクロロメタン
で抽出し硫酸マグネシウムで乾燥後、シリカゲルカラム
クロマトグラフィー(CH2Cl2)で精製し、さらに酢酸エ
チルで再結晶に付し融点166−168℃の下記式で示される
N−メチル−6−ニトロ−2,2−ジメチル−2H−1−ベ
ンゾピラン−4−カルボアミド0.25gを得た。
NMR (CDCl 3 , CF 3 CO 2 D): 1.25 (3H, s), 1.55 (3H, s), 3.
3 (3H, s), 4.1 (1H, d), 4.35 (1H, d), 6.9 (1H, d), 7.9
(1H, d), 8.1 (1H, dd) MS: 296 (M + ) (3) N-methyl-6-nitro-3,4-dihydro-3-
Hydroxy-2,2-dimethyl-2H-1-benzopyran-
A mixture of 0.42 g of 4-carbothioamide, 0.58 g of p-toluenesulfonyl chloride and 30 m of pyridine was heated under reflux for 3 hours. The reaction mixture was concentrated, 2N hydrochloric acid was added, extracted with dichloromethane, dried over magnesium sulfate, purified by silica gel column chromatography (CH 2 Cl 2 ), recrystallized with ethyl acetate, and melted at 166-168 ° C. 0.25 g of N-methyl-6-nitro-2,2-dimethyl-2H-1-benzopyran-4-carbamide represented by the following formula: was obtained.

NMR(CDCl3):1.5(6H,s),2.95(3H,d),6.0(1H,s),
6.8(1H,d),8.0(1H,dd),8.45(1H,d),5.6−6.4(1
H,m) MS:262(M+製造例11 N2−シアノ−N1,N1−ジメチル−6−ニトロ−2,2−ジメ
チル−2H−1−ベンゾピラン−4−カルボキサミジン (1)製造例10(3)に従って得られたN−メチル−6
−ニトロ−2,2−ジメチル−2H−1−ベンゾピラン−4
−カルボキサミド5.25g、ヨウ化メチル14.2gおよびテト
ラヒドロフラン50mの混合物に攪拌下、水素化ナトリ
ウム0.88gを加え、3時間加熱還流した。反応液に水を
加え塩化メチレンで抽出し、有機層を硫酸マグネシウム
で乾燥後減圧濃縮した。残渣にローソン試薬4.26gおよ
びトルエン20mを加え、1.5時間加熱還流した。反応液
を減圧濃縮後、残渣をシリカゲルカラムクロマトグラフ
ィ(展開液、塩化メチレン)に付し、さらに酢酸エチル
とn−ヘキサンの混合液より再結晶して融点139−141℃
のN,N−ジメチル−6−ニトロ−2,2−ジメチル−2H−1
−ベンゾピラン−4−カルボチオアミド4.86gを得た。
NMR (CDCl 3 ): 1.5 (6H, s), 2.95 (3H, d), 6.0 (1H, s),
6.8 (1H, d), 8.0 (1H, dd), 8.45 (1H, d), 5.6-6.4 (1
H, m) MS: 262 (M + ) Production Example 11 N 2 - cyano -N 1, N 1 - obtained according dimethyl-6-nitro-2,2-dimethyl-2H-1-benzopyran-4-carboxamidine (1) Preparation 10 (3) N- Methyl-6
-Nitro-2,2-dimethyl-2H-1-benzopyran-4
0.88 g of sodium hydride was added to a mixture of 5.25 g of carboxamide, 14.2 g of methyl iodide and 50 m of tetrahydrofuran with stirring, and the mixture was heated under reflux for 3 hours. Water was added to the reaction solution, and the mixture was extracted with methylene chloride. The organic layer was dried over magnesium sulfate and concentrated under reduced pressure. 4.26 g of Lawesson's reagent and 20 m of toluene were added to the residue, and the mixture was heated under reflux for 1.5 hours. After the reaction solution was concentrated under reduced pressure, the residue was subjected to silica gel column chromatography (developing solution, methylene chloride), and further recrystallized from a mixture of ethyl acetate and n-hexane to give a melting point of 139-141 ° C.
N, N-dimethyl-6-nitro-2,2-dimethyl-2H-1
4.86 g of -benzopyran-4-carbothioamide were obtained.

NMR(CDCl3):1.5(6H,s),3.2(3H,s),3.6(3H,s),
5.65(1H,s),6.85(1H,d),7.85(1H,d),8.05(1H,d
d) (2)N,N−ジメチル−6−ニトロ−2,2−ジメチル−2H
−1−ベンゾピラン−4−カルボチオアミド2.93g、ヨ
ウ化メチル4.11gおよびテトラヒドロフラン30mの混合
物を1時間加熱還流した。室温まで内温が下がったら、
シアナミド1.34gおよび水素化ナトリウム0.44gを加え、
1時間加熱還流した。反応液を減圧濃縮し塩化メチレン
を加え不溶物を濾別した。濾液を減圧濃縮し、残渣をシ
リカゲルカラムクロマトグラフィ(展開液、n−ヘキサ
ンと酢酸エチルの混合液)に付し、さらに酢酸エチルと
n−ヘキサンの混合液より再結晶し、融点209−211℃の
N2−シアノ−N1,N1−ジメチル−6−ニトロ−2,2−ジメ
チル−2H−1−ベンゾピラン−4−カルボキサミジン2.
57gを得た。
NMR (CDCl 3 ): 1.5 (6H, s), 3.2 (3H, s), 3.6 (3H, s),
5.65 (1H, s), 6.85 (1H, d), 7.85 (1H, d), 8.05 (1H, d
d) (2) N, N-dimethyl-6-nitro-2,2-dimethyl-2H
A mixture of 2.93 g of -1-benzopyran-4-carbothioamide, 4.11 g of methyl iodide and 30 m of tetrahydrofuran was heated under reflux for 1 hour. When the internal temperature drops to room temperature,
Add 1.34 g of cyanamide and 0.44 g of sodium hydride,
The mixture was refluxed for 1 hour. The reaction solution was concentrated under reduced pressure, methylene chloride was added, and insolubles were removed by filtration. The filtrate was concentrated under reduced pressure, the residue was subjected to silica gel column chromatography (developing solution, a mixed solution of n-hexane and ethyl acetate), and further recrystallized from a mixed solution of ethyl acetate and n-hexane to give a melting point of 209-211 ° C.
N 2 - cyano -N 1, N 1 - dimethyl-6-nitro-2,2-dimethyl-2H-1-benzopyran-4-carboxamidine 2.
57 g were obtained.

NMR(CDCl3):1.6(6H,s),3.0(3H,s),3.25(3H,s),
5.95(1H,s),6.95(1H,d),7.7(1H,d),8.1(1H,dd) MS:300(M+) IR(KBr):2172cm-1(C≡N) 製造例12 N−シアノ−N′−メチル−6−ニトロ−2,2−ジメチ
ル−2H−1−ベンゾピラン−4−カルボキサミジン (1)製造例10(3)に従って得られたN−メチル−6
−ニトロ−2,2−ジメチル−2H−1−ベンゾピラン−4
−カルボキサミド5.26g、ローソン試薬4.26gおよびベン
ゼン20mの混合物を、1.5時間加熱還流した。反応液を
減圧濃縮し、残渣をシリカゲルカラムクロマトグラフィ
ー(展開液、塩化メチレン)に付しさらに酢酸エチルと
n−ヘキサンの混合液より再結晶し、融点147−148℃の
N−メチル−6−ニトロ−2,2−ジメチル−2H−1−ベ
ンゾピラン−4−カルボチオアミド4.84gを得た。
NMR (CDCl 3 ): 1.6 (6H, s), 3.0 (3H, s), 3.25 (3H, s),
5.95 (1H, s), 6.95 (1H, d), 7.7 (1H, d), 8.1 (1H, dd) MS: 300 (M + ) IR (KBr): 2172cm -1 (C≡N) Production Example 12 N-Cyano-N'-methyl-6-nitro-2,2-dimethyl-2H-1-benzopyran-4-carboxamidine (1) N-methyl-6 obtained according to Production Example 10 (3)
-Nitro-2,2-dimethyl-2H-1-benzopyran-4
-A mixture of 5.26 g of carboxamide, 4.26 g of Lawesson's reagent and 20 m of benzene was heated under reflux for 1.5 hours. The reaction solution was concentrated under reduced pressure, the residue was subjected to silica gel column chromatography (developing solution, methylene chloride), and further recrystallized from a mixed solution of ethyl acetate and n-hexane to give N-methyl-6-p. 4.84 g of nitro-2,2-dimethyl-2H-1-benzopyran-4-carbothioamide were obtained.

(2)N−メチル−6−ニトロ−2,2−ジメチル−2H−
1−ベンゾピラン−4−カルボチオアミド0.56g、塩化
p−トルエンスルホニル0.39g、トリエチルアミン0.21g
およびアセトニトリル3mの混合物を30分間加熱還流し
た。溶媒を留去し、残渣にシアナミド0.27g、水素化ナ
トリウム0.17gおよびエタノール4mを加え30分間加熱
還流した。反応混合液に濃塩酸と水を加え塩化メチレン
で抽出した。有機層を2N炭酸カリウム水溶液および飽和
食塩水で洗浄し、硫酸マグネシウムで乾燥した。溶媒を
留去し、残渣をシリカゲルカラムクロマトグラフィー
(展開溶媒n−ヘキサン:酢酸エチル=1:1)に付し、
さらに酢酸エチルおよびジエチルエーテルの混合液で再
結晶し精製し、融点240−243℃の目的化合物50mgを得
た。
(2) N-methyl-6-nitro-2,2-dimethyl-2H-
1-benzopyran-4-carbothioamide 0.56 g, p-toluenesulfonyl chloride 0.39 g, triethylamine 0.21 g
And a mixture of 3 m of acetonitrile were heated to reflux for 30 minutes. The solvent was distilled off, and to the residue, 0.27 g of cyanamide, 0.17 g of sodium hydride and 4 m of ethanol were added, and the mixture was heated under reflux for 30 minutes. Concentrated hydrochloric acid and water were added to the reaction mixture, and the mixture was extracted with methylene chloride. The organic layer was washed with a 2N aqueous solution of potassium carbonate and a saturated saline solution, and dried over magnesium sulfate. The solvent was distilled off, and the residue was subjected to silica gel column chromatography (developing solvent n-hexane: ethyl acetate = 1: 1).
Further, the product was recrystallized and purified with a mixture of ethyl acetate and diethyl ether to obtain 50 mg of the desired compound having a melting point of 240-243 ° C.

NMR(CDCl3):1.6(6H,s),3.1(3H,d),5.9−6.2(1H,
bs),6.1(1H,s),6.9(1H,d),7.85(1H,d),8.1(1H,
dd) MS:286(M+) IR(KBr):2180cm-1(C≡N) 製造例13 N−(2′,2′,2′−トリフルオロエチル)−6−ニト
ロ−2,2−ジメチル−2H−1−ベンゾピラン−4−カル
ボアミド 6−ニトロ−2,2−ジメチル−2H−1−ベンゾピラン
−4−カルボン酸1.00g、2,2,2−トリフルオロエチルア
ミン0.44g、2,2′−ジピリジルジスルフィド0.97g、ト
リフェニルフォスフィン1.16gおよびジクロロメタン20m
の混合物を室温下3時間攪拌した。溶媒留去後、残渣
をシリカゲルクロマトグラフィー(展開液AcOEt:n−Hex
ane=1:1)で精製しさらにn−ヘキサンおよび酢酸エチ
ルの混合液で再結晶に付し融点178−180℃の下記式で示
されるN−(2′,2′,2′−トリフルオロエチル)−6
−ニトロ−2,2−ジメチル−2H−1−ベンゾピラン−4
−カルボアミド0.93gを得た。
NMR (CDCl 3): 1.6 ( 6H, s), 3.1 (3H, d), 5.9-6.2 (1H,
bs), 6.1 (1H, s), 6.9 (1H, d), 7.85 (1H, d), 8.1 (1H,
dd) MS: 286 (M + ) IR (KBr): 2180 cm -1 (C≡N) Production Example 13 N- (2 ', 2', 2'-trifluoroethyl) -6-nitro-2,2-dimethyl-2H-1-benzopyran-4-carbamide 6-nitro-2,2-dimethyl-2H -1-benzopyran-4-carboxylic acid 1.00 g, 2,2,2-trifluoroethylamine 0.44 g, 2,2'-dipyridyl disulfide 0.97 g, triphenylphosphine 1.16 g and dichloromethane 20 m
Was stirred at room temperature for 3 hours. After the solvent was distilled off, the residue was subjected to silica gel chromatography (developing solution AcOEt: n-Hex).
ane = 1: 1), recrystallized with a mixed solution of n-hexane and ethyl acetate, and having a melting point of 178-180 ° C. and N- (2 ′, 2 ′, 2′-trifluoro) represented by the following formula: Ethyl) -6
-Nitro-2,2-dimethyl-2H-1-benzopyran-4
0.93 g of carboxamide was obtained.

NMR(CDCl3):1.5(6H,s),3.7−4.4(2H,m),6.1(1H,
s),6.85(1H,d),8.05(1H,dd),8.4(1H,d). MS:330(M+製造例14 N−(N′−シアノ−6−ニトロ−2,2−ジメチル−2H
−1−ベンゾピラン−4−イルイミノイル)−ピロリジ
ン−3−オール N−(N′−シアノ−6−ニトロ−2,2−ジメチル−2
H−1−ベンゾピラン−4−イルイミノイル)−3−t
−ブチルジメチルシリルオキシピロリジン0.11g、テト
ラ−n−ブチルアンモニウム フルオリド(1mol/1のTH
F溶液)0.5mおよびテトラヒドロフラン5mの混合物
を氷冷下1時間攪拌した。溶媒留去後、残渣をシリカゲ
ルカラムクロマトグラフィー(AcOEt:n−Hexane=1:5)
で精製し、さらにn−ヘキサンおよび酢酸エチルの混合
液で再結晶に付し融点199−200℃の下記式で示されるN
−(N′−シアノ−6−ニトロ−2,2−ジメチル−2H−
1−ベンゾピラン−4−イルイミノイル)−ピロリジン
−3−オール28mgを得た。
NMR (CDCl 3): 1.5 ( 6H, s), 3.7-4.4 (2H, m), 6.1 (1H,
s), 6.85 (1H, d), 8.05 (1H, dd), 8.4 (1H, d). MS: 330 (M + ) Production Example 14 N- (N'-cyano-6-nitro-2,2-dimethyl-2H
-1-benzopyran-4-yliminoyl) -pyrrolidin-3-ol N- (N'-cyano-6-nitro-2,2-dimethyl-2
H-1-benzopyran-4-yliminoyl) -3-t
-Butyldimethylsilyloxypyrrolidine 0.11 g, tetra-n-butylammonium fluoride (1 mol / 1 TH
F solution) A mixture of 0.5 m and 5 m of tetrahydrofuran was stirred for 1 hour under ice cooling. After evaporation of the solvent, the residue was subjected to silica gel column chromatography (AcOEt: n-Hexane = 1: 5).
And then recrystallized with a mixture of n-hexane and ethyl acetate, and having a melting point of 199-200 ° C.
-(N'-cyano-6-nitro-2,2-dimethyl-2H-
28 mg of 1-benzopyran-4-yliminoyl) -pyrrolidin-3-ol were obtained.

NMR(CDCl3):1.6(6H,s),1.7−4.8(8H,m),6.0(1H,
s),6.9(1H,d),7.55−7.8(1H,m),8.05(1H,dd). MS:342(M+製造例15 N−エチル−6−トリフルオロメチル−2,2−ジメチル
−2H−1−ベンゾピラン−4−カルボアミド N−メチル−3,4−ジヒドロ−3−ヒドロキシ−6−
トリフルオロメチル−2,2−ジメチル−2H−1−ベンゾ
ピラン−4−カルボチオアミド0.17g、塩化p−トルエ
ンスルフォニル0.21gおよびピリジン10mの混合物を4
時間加熱還流後、2N塩酸を加えジクロロメタンで抽出し
硫酸マグネシウム乾燥後、シリカゲルカラムクロマトグ
ラフィー(CH2Cl2:Methanol=100:1)で精製し、さらに
ジエチルエーテルおよびn−ヘキサンの混合液で再結晶
に付し融点146−150℃の下記式で示されるN−メチル−
6−トリフルオロメチル−2,2−ジメチル−2H−1−ベ
ンゾピラン−4−カルボアミド44mgを得た。
NMR (CDCl 3): 1.6 ( 6H, s), 1.7-4.8 (8H, m), 6.0 (1H,
s), 6.9 (1H, d), 7.55-7.8 (1H, m), 8.05 (1H, dd). MS: 342 (M + ) Production Example 15 N-ethyl-6-trifluoromethyl-2,2-dimethyl-2H-1-benzopyran-4-carbamide N-methyl-3,4-dihydro-3-hydroxy-6
A mixture of 0.17 g of trifluoromethyl-2,2-dimethyl-2H-1-benzopyran-4-carbothioamide, 0.21 g of p-toluenesulfonyl chloride and 10 m of pyridine was added to 4
After heating under reflux for 2 hours, 2N hydrochloric acid was added, the mixture was extracted with dichloromethane, dried over magnesium sulfate, purified by silica gel column chromatography (CH 2 Cl 2 : Methanol = 100: 1), and re-used with a mixture of diethyl ether and n-hexane. N-methyl- having a melting point of 146-150 ° C. and having the following formula
44 mg of 6-trifluoromethyl-2,2-dimethyl-2H-1-benzopyran-4-carbamide were obtained.

NMR(CDCl3):1.4(6H,s),2.85(3H,d),5.95(1H,
s),6.1−6.7(1H,m),6.8(1H,d),6.35(1H,dd),7.7
5(1H,d). MS:285(M+製造例16 N−メチル−6−シアノ−2−エチル−2−メチル−2H
−1−ベンゾピラン−4−カルボアミド N−メチル−6−シアノ−2−エチル−2−メチル−
2H−1−ベンゾピラン−4−カルボチオアミド70mg、塩
化p−トルエンスルフォニル55mgおよびピリジン5mの
混合物を6時間加熱還流後、2N塩酸を加えジクロロメタ
ンで抽出し硫酸マグネシウムで乾燥後、シリカゲルカラ
ムクロマトグラフィー(AcOEt:n−Hexane=1:1)で精製
し、さらに酢酸エチルおよびn−ヘキサンの混合液で再
結晶に付し融点152−154℃の下記式で示されるN−メチ
ル−6−シアノ−2−エチル−2−メチル−2H−1−ベ
ンゾピラン−4−カルボアミド41mgを得た。
NMR (CDCl 3): 1.4 ( 6H, s), 2.85 (3H, d), 5.95 (1H,
s), 6.1-6.7 (1H, m), 6.8 (1H, d), 6.35 (1H, dd), 7.7
5 (1H, d). MS: 285 (M + ) Production Example 16 N-methyl-6-cyano-2-ethyl-2-methyl-2H
-1-benzopyran-4-carbamide N-methyl-6-cyano-2-ethyl-2-methyl-
After heating a mixture of 70 mg of 2H-1-benzopyran-4-carbothioamide, 55 mg of p-toluenesulfonyl chloride and 5 m of pyridine under reflux for 6 hours, adding 2N hydrochloric acid, extracting with dichloromethane, drying over magnesium sulfate, and silica gel column chromatography (AcOEt chromatography). : n-Hexane = 1: 1), and further recrystallized with a mixture of ethyl acetate and n-hexane to give N-methyl-6-cyano-2- having a melting point of 152-154 ° C and represented by the following formula. 41 mg of ethyl-2-methyl-2H-1-benzopyran-4-carbamide were obtained.

NMR(CDCl3):0.95(3H,t),1.4(3H,s),1.8(2H,q),
2.9(3H,d),6.0(1H,s),6.2−6.7(1H,m),6.8(1H,
d),7.4(1H,dd),7.85(1H,d). MS:256(M+製造例17 N−エチル−N−メチル−6−ニトロ−2,2−ジメチル
−2H−1−ベンゾピラン−4−カルボアミド N−メチル−6−ニトロ−2,2−ジメチル−2H−1−
ベンゾピラン−4−カルボアミド0.53g、ヨウ化エチル
1.60g、水素化ナトリウム0.09gおよびテトラヒドロフラ
ン10mの混合物を30分加熱還流後、ジクロロメタンを
加え不溶物を濾別した。さらにジエチルエーテルおよび
n−ヘキサンの混合液で再結晶に付し融点121−124℃の
下記式で示されるN−エチル−N−メチル−6−ニトロ
−2,2−ジメチル−2H−1−ベンゾピラン−4−カルボ
アミド0.45gを得た。
NMR (CDCl 3 ): 0.95 (3H, t), 1.4 (3H, s), 1.8 (2H, q),
2.9 (3H, d), 6.0 (1H, s), 6.2-6.7 (1H, m), 6.8 (1H,
d), 7.4 (1H, dd), 7.85 (1H, d). MS: 256 (M + ) Production Example 17 N-ethyl-N-methyl-6-nitro-2,2-dimethyl-2H-1-benzopyran-4-carbamide N-methyl-6-nitro-2,2-dimethyl-2H-1-
Benzopyran-4-carbamide 0.53 g, ethyl iodide
A mixture of 1.60 g, 0.09 g of sodium hydride and 10 m of tetrahydrofuran was heated under reflux for 30 minutes, dichloromethane was added, and insolubles were filtered off. The mixture was recrystallized with a mixed solution of diethyl ether and n-hexane, and N-ethyl-N-methyl-6-nitro-2,2-dimethyl-2H-1-benzopyran represented by the following formula having a melting point of 121-124 ° C. 0.45 g of -4-carbamide was obtained.

NMR(CDCl3):0.9−1.5(3H,m),1.5(6H,s),2.8−3.8
(5H,m),5.7(1H,s),6.95(1H,d),7.9(1H,d),8.1
(1H,dd). MS:290(M+製造例18〜20 N−シアノ−6−ニトロ−2,2−ジメチル−2H−1−ベ
ンゾピラン−4−イミド酸エチル N−シアノ−6−ニトロ−2,2−ジメチル−2H−1−ベ
ンゾピラン−4−アミジン 6−ニトロ−2,2−ジメチル−2H−1−ベンゾピラン−
4−カルボン酸エチル 4−シアノ−6−ニトロ−2,2−ジメチル−2H−1−
ベンゾピラン1.04gおよびエチルアルコール20mの混合
物に氷冷攪拌下、塩酸ガスを過飽和状態になるまで加え
6日間5℃にて攪拌した。反応液を濃縮後、残渣にジエ
チルエーテルおよびエチルアルコールの1:1混合液を加
えトリチュレーション後、結晶を濾取し、エチルアルコ
ールとジエチルエーテルの混合液で洗い乾燥し6−ニト
ロ−2,2−ジメチル−2H−1−ベンゾピラン−4−イミ
ド酸エチル塩酸塩1.13gを得た。次いで得られた本化合
物0.94g、トリエチルアミン0.31g、シアナミド0.13gお
よびエチルアルコール7mの混合物を室温下、6時間攪
拌した。反応液濃縮後、水を加えジクロロメタンで抽出
し2N塩酸で洗浄後、硫酸マグネシウムで乾燥した。さら
にシリカゲルカラムクロマトグラフィー(AcOEt:n−Hex
ane=1:1)に付し極性の異なる成分を単離した。最も極
性の低い成分は、さらにジエチルエーテルおよびn−ヘ
キサンの混合液で再結晶に付し融点96−97℃の下記式で
示される6−ニトロ−2,2−ジメチル−2H−1−ベンゾ
ピラン−4−カルボン酸エチル0.15gを得た。
NMR (CDCl 3): 0.9-1.5 ( 3H, m), 1.5 (6H, s), 2.8-3.8
(5H, m), 5.7 (1H, s), 6.95 (1H, d), 7.9 (1H, d), 8.1
(1H, dd). MS: 290 (M + ) Production Examples 18-20 Ethyl N-cyano-6-nitro-2,2-dimethyl-2H-1-benzopyran-4-imidate N-cyano-6-nitro-2,2-dimethyl-2H-1-benzopyran- 4-amidine 6-nitro-2,2-dimethyl-2H-1-benzopyran-
Ethyl 4-carboxylate 4-cyano-6-nitro-2,2-dimethyl-2H-1-
Hydrochloric acid gas was added to a mixture of 1.04 g of benzopyran and 20 m of ethyl alcohol under ice cooling and stirring until the mixture became supersaturated, and the mixture was stirred at 5 ° C. for 6 days. After concentration of the reaction solution, a 1: 1 mixture of diethyl ether and ethyl alcohol was added to the residue, and the mixture was triturated. The crystals were collected by filtration, washed with a mixture of ethyl alcohol and diethyl ether and dried to give 6-nitro-2, 1.13 g of ethyl 2-dimethyl-2H-1-benzopyran-4-imidate hydrochloride were obtained. Next, a mixture of the obtained present compound (0.94 g), triethylamine (0.31 g), cyanamide (0.13 g) and ethyl alcohol (7 m) was stirred at room temperature for 6 hours. After concentration of the reaction solution, water was added, extracted with dichloromethane, washed with 2N hydrochloric acid, and dried over magnesium sulfate. Furthermore, silica gel column chromatography (AcOEt: n-Hex
ane = 1: 1) to isolate components of different polarities. The least polar component is further recrystallized with a mixture of diethyl ether and n-hexane to give 6-nitro-2,2-dimethyl-2H-1-benzopyran- 0.15 g of ethyl 4-carboxylate was obtained.

NMR(CDCl3):1.4(3H,t),1.5(6H,s),4.35(2H,q),
6.8(1H,s),6.85(1H,d),8.05(1H,dd),9.0(1H,
d). MS:277(M+ 次に極性の低い成分は、さらに酢酸エチルおよびn−
ヘキサンの混合液で再結晶に付し融点91−93℃の下記式
で示されるN−シアノ−6−ニトロ−2,2−ジメチル−2
H−1−ベンゾピラン−4−イミド酸エチル0.14gを得
た。
NMR (CDCl 3 ): 1.4 (3H, t), 1.5 (6H, s), 4.35 (2H, q),
6.8 (1H, s), 6.85 (1H, d), 8.05 (1H, dd), 9.0 (1H,
d). MS: 277 (M + ) The next less polar component is further ethyl acetate and n-
N-cyano-6-nitro-2,2-dimethyl-2 represented by the following formula having a melting point of 91-93 ° C.
0.14 g of ethyl H-1-benzopyran-4-imidate was obtained.

NMR(CDCl3):1.5(3H,t),1.6(6H,s),4.6(2H,q),
6.5(1H,s),6.85−7.1(1H,m),8.0−8.3(2H,m). MS:301(M+ 最も極性の高い成分は、さらに酢酸エチルおよびn−
ヘキサンの混合液で再結晶に付し融点205−207℃の下記
式で示されるN−シアノ−6−ニトロ−2,2−ジメチル
−2H−1−ベンゾピラン−4−アミジン0.08gを得た。
NMR (CDCl 3 ): 1.5 (3H, t), 1.6 (6H, s), 4.6 (2H, q),
6.5 (1H, s), 6.85-7.1 (1H, m), 8.0-8.3 (2H, m). MS: 301 (M + ) The most polar components are additionally ethyl acetate and n-
The mixture was recrystallized from a mixed solution of hexane to obtain 0.08 g of N-cyano-6-nitro-2,2-dimethyl-2H-1-benzopyran-4-amidine represented by the following formula and having a melting point of 205-207 ° C.

NMR(CDCl3):1.5(6H,s),5.6−6.5(2H,m),6.2(1H,
s),6.9(1H,d),8.05(1H,dd),8.55(1H,d). MS:272(M+製造例21 N−シアノ−N′−シクロプロピル−6−ニトロ−2,2
−ジメチル−2H−1−ベンゾピラン−4−アミジン N−シアノ−6−ニトロ−2,2−ジメチル−2H−1−
ベンゾピラン−4−イミド酸エチル98mg、シクロプロピ
ルアミンおよびジクロロメタン1mの混合物を室温下、
1.5時間攪拌後、シリカゲルカラムクロマトグラフィー
(AcOEt:n−Hexane=1:1)で精製し、さらにアセトンお
よびn−ヘキサンの混合液で再結晶に付し融点206−207
℃の下記式で示されるN−シアノ−N′−シクロプロピ
ル−6−ニトロ−2,2−ジメチル−2H−1−ベンゾピラ
ン−4−アミジン30mgを得た。
NMR (CDCl 3): 1.5 ( 6H, s), 5.6-6.5 (2H, m), 6.2 (1H,
s), 6.9 (1H, d), 8.05 (1H, dd), 8.55 (1H, d). MS: 272 (M + ) Production Example 21 N-cyano-N'-cyclopropyl-6-nitro-2,2
-Dimethyl-2H-1-benzopyran-4-amidine N-cyano-6-nitro-2,2-dimethyl-2H-1-
A mixture of 98 mg of ethyl benzopyran-4-imidate, cyclopropylamine and 1 m of dichloromethane was added at room temperature,
After stirring for 1.5 hours, the mixture was purified by silica gel column chromatography (AcOEt: n-Hexane = 1: 1), and further recrystallized with a mixture of acetone and n-hexane to give a melting point of 206-207.
There was obtained 30 mg of N-cyano-N'-cyclopropyl-6-nitro-2,2-dimethyl-2H-1-benzopyran-4-amidine represented by the following formula.

NMR(CDCl3):0.5−1.0(4H,m),1.5(6H,s),2.7−3.2
(1H,m),5.9(1H,s),6.8(1H,d),6.9−7.4(1H,m),
7.7(1H,d),8.0(1H,dd). MS:312(M+製造例22 N−メチル−3,4−ジヒドロ−6−ニトロ−2,2−ジメチ
ル−2H−1−ベンゾピラン−4−カルボアミド N−メチル−6−ニトロ−2,2−ジメチル−2H−1−
ベンゾピラン−4−カルボアミド0.53g、水素化ホウ素
ナトリウム0.38g、テトラヒドロフラン5mおよびメチ
ルアルコール5mの混合物を室温下、20分攪拌後、2N塩
酸を加えジクロロメタンで抽出し硫酸マグネシウムで乾
燥後、さらに酢酸エチルおよびn−ヘキサンで再結晶し
融点161−162℃の下記式で示されるN−メチル−3,4−
ジヒドロ−6−ニトロ−2,2−ジメチル−2H−1−ベン
ゾピラン−4−カルボアミド0.42gを得た。
NMR (CDCl 3): 0.5-1.0 ( 4H, m), 1.5 (6H, s), 2.7-3.2
(1H, m), 5.9 (1H, s), 6.8 (1H, d), 6.9-7.4 (1H, m),
7.7 (1H, d), 8.0 (1H, dd). MS: 312 (M + ) Production Example 22 N-methyl-3,4-dihydro-6-nitro-2,2-dimethyl-2H-1-benzopyran-4-carbamide N-methyl-6-nitro-2,2-dimethyl-2H-1-
A mixture of 0.53 g of benzopyran-4-carbamide, 0.38 g of sodium borohydride, 5 m of tetrahydrofuran and 5 m of methyl alcohol was stirred at room temperature for 20 minutes, 2N hydrochloric acid was added, extracted with dichloromethane, dried over magnesium sulfate, further ethyl acetate and Recrystallized from n-hexane and having a melting point of 161-162 ° C, N-methyl-3,4- represented by the following formula:
0.42 g of dihydro-6-nitro-2,2-dimethyl-2H-1-benzopyran-4-carbamide was obtained.

NMR(CDCl3):1.3(3H,s),1.4(3H,s),1.9−2.4(2H,
m),2.85(3H,d),3.7(1H,dd),5.7−6.3(1H,m),6.8
5(1H,d),7.85−8.2(2H,m). MS:264(M+製造例23 N,N−ジメチル−3,4−ジヒドロ−6−ニトロ−2,2−ジ
メチル−2H−1−ベンゾピラン−4−カルボアミド N−メチル−6−ニトロ−2,2−ジメチル−2H−1−
ベンゾピラン−4−カルボアミド2.63g、水素化ホウ素
ナトリウム1.90g、テトラヒドロフラン25mおよびメチ
ルアルコール25mの混合物を室温下20分攪拌後、2N塩
酸を加えジクロロメタンで抽出し硫酸マグネシウムで乾
燥した。溶媒を留去後、残渣にヨウ化メタン7.1g、水素
化ナトリウム0.44gおよびテトラヒドロフラン50mを加
え30分加熱還流後、2N塩酸を加えジクロロメタンで抽出
し、飽和食塩水で洗浄後、硫酸マグネシウムで乾燥し
た。さらにシリカゲルカラムクロマトグラフィー(CH2C
l2)で精製し酢酸エチルおよびn−ヘキサンの混合液で
再結晶し融点162−164℃の下記式で示されるN,N−ジメ
チル−3,4−ジヒドロ−6−ニトロ−2,2−ジメチル−2H
−1−ベンゾピラン−4−カルボアミド0.49gを得た。
NMR (CDCl 3): 1.3 ( 3H, s), 1.4 (3H, s), 1.9-2.4 (2H,
m), 2.85 (3H, d), 3.7 (1H, dd), 5.7-6.3 (1H, m), 6.8
5 (1H, d), 7.85-8.2 (2H, m). MS: 264 (M + ) Production Example 23 N, N-dimethyl-3,4-dihydro-6-nitro-2,2-dimethyl-2H-1-benzopyran-4-carbamide N-methyl-6-nitro-2,2-dimethyl-2H- 1-
A mixture of 2.63 g of benzopyran-4-carbamide, 1.90 g of sodium borohydride, 25 m of tetrahydrofuran and 25 m of methyl alcohol was stirred at room temperature for 20 minutes, 2N hydrochloric acid was added, and the mixture was extracted with dichloromethane and dried over magnesium sulfate. After evaporating the solvent, 7.1 g of methane iodide, 0.44 g of sodium hydride and 50 m of tetrahydrofuran were added to the residue, and the mixture was heated under reflux for 30 minutes, 2N hydrochloric acid was added, and the mixture was extracted with dichloromethane, washed with saturated saline, and dried over magnesium sulfate. did. In addition, silica gel column chromatography (CH 2 C
N represented by the following formula recrystallized mp 162-164 ° C. with a mixture of purified ethyl acetate and n- hexane l 2), N-dimethyl-3,4-dihydro-6-nitro-2,2 Dimethyl-2H
0.49 g of -1-benzopyran-4-carbamide was obtained.

NMR(CDCl3):1.35(3H,s),1.5(3H,s),1.75−2.5(2
H,m),2.1(3H,s),2.25(3H,s),4.2(1H,dd),6.85
(1H,d),7.8−8.2(2H,m). MS:278(M+製造例24 N,N−ジメチル−3,4−ジヒドロ−6−ニトロ−2,2−ジ
メチル−2H−1−ベンゾピラン−4−カルボチオアミド N,N−ジメチル−3,4−ジヒドロ−6−ニトロ−2,2−
ジメチル−2H−1−ベンゾピラン−4−カルボアミド0.
43g、ローソン試薬0.33gおよびベンゼン2mの混合液を
30分加熱還流後、シリカゲルカラムクロマトグラフィー
(CH2CH2)で精製し、さらに酢酸エチルおよびn−ヘキ
サンの混合液で再結晶し融点158−160℃の下記式で示さ
れるN,N−ジメチル−3,4−ジヒドロ−6−ニトロ−2,2
−ジメチル−2H−1−ベンゾピラン−4−カルボチオア
ミド0.33gを得た。
NMR (CDCl 3): 1.35 ( 3H, s), 1.5 (3H, s), 1.75-2.5 (2
H, m), 2.1 (3H, s), 2.25 (3H, s), 4.2 (1H, dd), 6.85
(1H, d), 7.8-8.2 (2H, m). MS: 278 (M + ) Production Example 24 N, N-dimethyl-3,4-dihydro-6-nitro-2,2-dimethyl-2H-1-benzopyran-4-carbothioamide N, N-dimethyl-3,4-dihydro-6-nitro −2,2−
Dimethyl-2H-1-benzopyran-4-carbamide 0.
43 g, a mixture of Lawson's reagent 0.33 g and benzene 2 m
After heating and refluxing for 30 minutes, the mixture was purified by silica gel column chromatography (CH 2 CH 2 ), and further recrystallized from a mixture of ethyl acetate and n-hexane to give N, N-dimethyl represented by the following formula having a melting point of 158-160 ° C. -3,4-dihydro-6-nitro-2,2
-Dimethyl-2H-1-benzopyran-4-carbothioamide 0.33 g was obtained.

NMR(CDCl3):1.3(3H,s),1.5(3H,s),1.8−2.7(2H,
m),3.3(3H,s),3.6(3H,s),4.6(1H,dd),6.8(1H,
d),7.75−8.2(2H,m). MS:294(M+製造例25 N−シアノ−N′,N′−ジメチル−3,4−ジヒドロ−6
−ニトロ−2,2−ジメチル−2H−1−ベンゾピラン−4
−アミジン N,N−ジメチル−3,4−ジヒドロ−6−ニトロ−2,2−
ジメチル−2H−1−ベンゾピラン−4−カルボチオアミ
ド0.27g、ヨウ化メチル0.66gおよびテトラヒドロフラン
2mの混合物を1時間加熱還流後、さらに水素化ナトリ
ウム40mgおよびシアナミド44mgを加え2時間加熱還流し
た。ジクロロメタンを加え不溶物を濾別し残渣をシリカ
ゲルカラムクロマトグラフィー(AcOEt:n−Hexane=1:
1)で精製し酢酸エチルおよびn−ヘキサンの混合液で
再結晶し融点222−224℃の下記式で示されるN−シアノ
−N′,N′−ジメチル−3,4−ジヒドロ−6−ニトロ−
2,2−ジメチル−2H−1−ベンゾピラン−4−アミジン9
0mgを得た。
NMR (CDCl 3): 1.3 ( 3H, s), 1.5 (3H, s), 1.8-2.7 (2H,
m), 3.3 (3H, s), 3.6 (3H, s), 4.6 (1H, dd), 6.8 (1H,
d), 7.75-8.2 (2H, m). MS: 294 (M + ) Production Example 25 N-cyano-N ', N'-dimethyl-3,4-dihydro-6
-Nitro-2,2-dimethyl-2H-1-benzopyran-4
-Amidine N, N-dimethyl-3,4-dihydro-6-nitro-2,2-
Dimethyl-2H-1-benzopyran-4-carbothioamide 0.27 g, methyl iodide 0.66 g and tetrahydrofuran
After heating and refluxing the 2 m mixture for 1 hour, 40 mg of sodium hydride and 44 mg of cyanamide were further added, and the mixture was heated and refluxed for 2 hours. Dichloromethane was added, insolubles were removed by filtration, and the residue was subjected to silica gel column chromatography (AcOEt: n-Hexane = 1: 1).
Purified in 1), recrystallized from a mixture of ethyl acetate and n-hexane, and having a melting point of 222-224 ° C, N-cyano-N ', N'-dimethyl-3,4-dihydro-6-nitro −
2,2-dimethyl-2H-1-benzopyran-4-amidine 9
0 mg was obtained.

NMR(CDCl3):1.35(3H,s),1.6(3H,s),1.8−5.5(9
H,m),6.95(1H,d),7.8−8.3(2H,m). MS:302(M+製造例26 N−ヒドロキシ−N′,N′−ジメチル−6−ニトロ−2,
2−ジメチル−2H−1−ベンゾピラン−4−アミジン N,N−ジメチル−6−ニトロ−2,2−ジメチル−2H−1
−ベンゾピラン−4−カルボチオアミド0.30g、ヨウ化
メチル2.5gおよびテトラヒドロフラン10mの混合物を3
0分加熱還流後、さらにヒドロキシルアミン塩酸塩0.37g
およびトリエチルアミン0.15gを加え1.5時間加熱還流し
た。炭酸カリウム水溶液を加えジクロロメタンで抽出し
硫酸マグネシウムで乾燥後、シリカゲルカラムクロマト
グラフィー(AcOEt:n−Hexane=1:1)で精製しさらにジ
クロロメタンおよびn−ヘキサンの混合液で再結晶し下
記式で示されるN−ヒドロキシ−N′,N′−ジメチル−
6−ニトロ−2,2−ジメチル−2H−1−ベンゾピラン−
4−アミジン72mgを得た。
NMR (CDCl 3): 1.35 ( 3H, s), 1.6 (3H, s), 1.8-5.5 (9
H, m), 6.95 (1H, d), 7.8-8.3 (2H, m). MS: 302 (M + ) Production Example 26 N-hydroxy-N ', N'-dimethyl-6-nitro-2,
2-dimethyl-2H-1-benzopyran-4-amidine N, N-dimethyl-6-nitro-2,2-dimethyl-2H-1
A mixture of 0.30 g of benzopyran-4-carbothioamide, 2.5 g of methyl iodide and 10 m of tetrahydrofuran
After heating and refluxing for 0 minutes, further 0.37 g of hydroxylamine hydrochloride
And 0.15 g of triethylamine, and the mixture was heated under reflux for 1.5 hours. An aqueous potassium carbonate solution was added, the mixture was extracted with dichloromethane, dried over magnesium sulfate, purified by silica gel column chromatography (AcOEt: n-Hexane = 1: 1), further recrystallized with a mixture of dichloromethane and n-hexane, and represented by the following formula. N-hydroxy-N ', N'-dimethyl-
6-nitro-2,2-dimethyl-2H-1-benzopyran-
72 mg of 4-amidine were obtained.

NMR(CDCl3):1.55(6H,s),2.75(6H,s),5.8(1H,
s),6.9(1H,d),7.4−8.2(3H,m). MS:291(M+製造例27 N−スルファモイル−N′,N′−ジメチル−6−ニトロ
−2,2−ジメチル−2H−1−ベンゾピラン−4−アミジ
ン N,N−ジメチル−6−ニトロ−2,2−ジメチル−2H−1
−ベンゾピラン−4−カルボチオアミド0.29g、ヨウ化
メチル0.71gおよびテトラヒドロフラン2mの混合物を3
0分加熱還流後、さらにスルファミド105mgおよび水素化
ナトリウム44mgを加え、5時間加熱還流した。2N塩酸を
加えジクロロメタンで抽出し、飽和食塩水で洗浄後、硫
酸マグネシウムで乾燥しシリカゲルカラムクロマトグラ
フィー(AcOEt:n−Hexane=1:1)で精製し酢酸エチルお
よびn−ヘキサンの混合液で再結晶し融点212−214℃の
下記式で示されるN−スルファモイル−N′,N′−ジメ
チル−6−ニトロ−2,2−ジメチル−2H−1−ベンゾピ
ラン−4−アミジン0.17gを得た。
NMR (CDCl 3 ): 1.55 (6H, s), 2.75 (6H, s), 5.8 (1H,
s), 6.9 (1H, d), 7.4-8.2 (3H, m). MS: 291 (M + ) Production Example 27 N-Sulfamoyl-N ', N'-dimethyl-6-nitro-2,2-dimethyl-2H-1-benzopyran-4-amidine N, N-dimethyl-6-nitro-2,2-dimethyl- 2H-1
A mixture of 0.29 g of benzopyran-4-carbothioamide, 0.71 g of methyl iodide and 2 m of tetrahydrofuran
After heating under reflux for 0 minutes, 105 mg of sulfamide and 44 mg of sodium hydride were further added, and the mixture was heated under reflux for 5 hours. After adding 2N hydrochloric acid, the mixture is extracted with dichloromethane, washed with saturated saline, dried over magnesium sulfate, purified by silica gel column chromatography (AcOEt: n-Hexane = 1: 1), and re-used with a mixture of ethyl acetate and n-hexane. Crystallization gave 0.17 g of N-sulfamoyl-N ', N'-dimethyl-6-nitro-2,2-dimethyl-2H-1-benzopyran-4-amidine represented by the following formula and having a melting point of 212-214 ° C.

NMR(CDCl3):1.55(3H,s),1.6(3H,s),2.9(3H,s),
3.2(3H,s),4.4−4.8(2H,m),5.95(1H,s),6.9(1H,
d),7.7(1H,d),8.1(1H,dd). MS:354(M+製造例28 N−カルバモイル−N′,N′−ジメチル−6−ニトロ−
2,2−ジメチル−2H−1−ベンゾピラン−4−アミジン N−シアノ−N′,N′−ジメチル−6−ニトロ−2,2
−ジメチル−2H−1−ベンゾピラン−4−アミジン300m
g、エチルアルコール10mおよびクロロホルム10mの
混合物に氷冷下、塩酸ガスを飽和するまで加え10日間6
℃にて攪拌した。反応液を濃縮し、飽和炭酸水素ナトリ
ウム水を加えジクロロメタンで抽出し硫酸ナトリウムで
乾燥後、シリカゲルカラムクロマトグラフィー(AcOEt:
n−Hexane=3:1)で精製し、さらに酢酸エチルおよびn
−ヘキサンの混合液で再結晶し融点157−159℃の下記式
で示されるN−カルバモイル−N′,N′−ジメチル−6
−ニトロ−2,2−ジメチル−2H−1−ベンゾピラン−4
−アミジン236mgを得た。
NMR (CDCl 3 ): 1.55 (3H, s), 1.6 (3H, s), 2.9 (3H, s),
3.2 (3H, s), 4.4−4.8 (2H, m), 5.95 (1H, s), 6.9 (1H,
d), 7.7 (1H, d), 8.1 (1H, dd). MS: 354 (M + ) Production Example 28 N-carbamoyl-N ', N'-dimethyl-6-nitro-
2,2-dimethyl-2H-1-benzopyran-4-amidine N-cyano-N ', N'-dimethyl-6-nitro-2,2
-Dimethyl-2H-1-benzopyran-4-amidine 300 m
g, a mixture of 10 m of ethyl alcohol and 10 m of chloroform was added under ice-cooling until hydrochloric acid gas was saturated.
Stirred at ° C. The reaction mixture was concentrated, saturated aqueous sodium hydrogen carbonate was added, extracted with dichloromethane, dried over sodium sulfate, and then subjected to silica gel column chromatography (AcOEt:
n-Hexane = 3: 1) and further purified with ethyl acetate and n
N-carbamoyl-N ', N'-dimethyl-6 represented by the following formula having a melting point of 157-159 ° C.
-Nitro-2,2-dimethyl-2H-1-benzopyran-4
-236 mg of amidine were obtained.

NMR(CDCl3):1.5(3H,s),1.55(3H,s),2.9(3H,s),
3.15(3H,s),4.6−5.4(2H,m),5.7(1H,s),6.85(1
H,d),7.8(1H,d),8.05(1H,dd). MS:318(M+製造例29 3−ヒドロキシ−2,2−ジメチル−6−ニトロ−2H−1
−ベンゾピラン−4−カルボアミド 3,4−ジヒドロ−2,2−ジメチル−6−ニトロ−2H−1
−ベンゾピラン−3−オン41.5gおよび乾燥N,N−ジメチ
ルホルムアミド500mの混合物に、窒素気流下、氷冷で
攪拌しながら、ナトリウムハイドライド(60%)8.2gを
徐々に加え50分攪拌した後、カルボニルジイミダゾール
33.5g加え1時間攪拌した後、塩化アンモニウム11.2gお
よびトリエチルアミン29mを加え、5℃で12時間攪拌
した後、室温で14時間攪拌した。氷水を加えエーテルで
洗った。水層を塩酸酸性にし、酢酸エチルとエーテルの
混合溶媒で抽出した。有機層を水洗乾燥後、溶媒を留去
して得た残渣をシリカゲルカラムクロマトグラフィー
(展開液:CH2Cl2:MeOH=99:1)で精製して融点189−191
℃の下記式で表される3−ヒドロキシ−2,2−ジメチル
−6−ニトロ−2H−1−ベンゾピラン−4−カルボアミ
ド23.2gを得た。
NMR (CDCl 3 ): 1.5 (3H, s), 1.55 (3H, s), 2.9 (3H, s),
3.15 (3H, s), 4.6-5.4 (2H, m), 5.7 (1H, s), 6.85 (1
H, d), 7.8 (1H, d), 8.05 (1H, dd). MS: 318 (M + ) Production Example 29 3-hydroxy-2,2-dimethyl-6-nitro-2H-1
-Benzopyran-4-carbamide 3,4-dihydro-2,2-dimethyl-6-nitro-2H-1
To a mixture of 41.5 g of -benzopyran-3-one and 500 m of dry N, N-dimethylformamide, 8.2 g of sodium hydride (60%) was gradually added while stirring under ice-cooling under a nitrogen stream, followed by stirring for 50 minutes. Carbonyldiimidazole
After adding 33.5 g and stirring for 1 hour, 11.2 g of ammonium chloride and 29 m of triethylamine were added, and the mixture was stirred at 5 ° C for 12 hours and then at room temperature for 14 hours. Ice water was added and washed with ether. The aqueous layer was acidified with hydrochloric acid and extracted with a mixed solvent of ethyl acetate and ether. The organic layer was washed with water and dried, and the residue obtained by evaporating the solvent was purified by silica gel column chromatography (eluent: CH 2 Cl 2 : MeOH = 99: 1) to give a melting point of 189-191.
23.2 g of 3-hydroxy-2,2-dimethyl-6-nitro-2H-1-benzopyran-4-carboxamide represented by the following formula at a temperature of ° C. was obtained.

NMR(CDCl3−CD3OD):1.50(6H,s),7.00(1H,d),7.97
(1H,dd),8.27(1H,d). MS:264(M+製造例30 2,2−ジメチル−6−ニトロ−2H−1−ベンゾピラン−
4−カルボン酸 3−ヒドロキシ−2,2−ジメチル−6−ニトロ−2H−
1−ベンゾピラン−4−カルボアミド23.2g、ナトリウ
ムシアノボロハイドライド16.6gおよびテトラヒドロフ
ラン200mの混合物に、氷冷攪拌下、酢酸100m加え、
氷冷下で3時間攪拌し、室温で18時間攪拌した後、ナト
リウムシアノボロハイドライド5.6gとメタノール50m
追加し、室温で40時間攪拌した。反応液を減圧留去し、
水を加え酢酸エチルとエーテルの混合溶媒で抽出した。
有機層を水洗乾燥後、溶媒を留去して24gの3,4−ジヒド
ロ−3−ヒドロキシ−2,2−ジメチル−6−ニトロ−2H
−1−ベンゾピラン−4−カルボアミドを得た。次い
で、これにパラトルエンスルホニルクロライド51.5gお
よびピリジン400mを加え3時間加熱還流した後、溶媒
を留去した。残渣に氷水を加え、塩酸酸性にして折出す
る結晶を濾取し、水洗し乾燥した。この結晶をシリカゲ
ルクロマトグラフィー(展開液:CH2Cl2:ヘキサン=7:
3)で精製して融点162−164℃の下記式で表される4−
シアノ−2,2−ジメチル−6−ニトロ−2H−1−ベンゾ
ピラン17.9gを得た。
NMR (CDCl 3 -CD 3 OD) : 1.50 (6H, s), 7.00 (1H, d), 7.97
(1H, dd), 8.27 (1H, d). MS: 264 (M + ) Production Example 30 2,2-dimethyl-6-nitro-2H-1-benzopyran-
4-carboxylic acid 3-hydroxy-2,2-dimethyl-6-nitro-2H-
To a mixture of 13.2 g of 1-benzopyran-4-carbamide, 16.6 g of sodium cyanoborohydride and 200 m of tetrahydrofuran, 100 m of acetic acid was added under ice-cooling and stirring.
After stirring for 3 hours under ice-cooling and stirring for 18 hours at room temperature, 5.6 g of sodium cyanoborohydride and 50 m of methanol
Added and stirred at room temperature for 40 hours. The reaction solution was distilled off under reduced pressure,
Water was added, and the mixture was extracted with a mixed solvent of ethyl acetate and ether.
The organic layer was washed with water and dried, and the solvent was distilled off to obtain 24 g of 3,4-dihydro-3-hydroxy-2,2-dimethyl-6-nitro-2H.
-1-benzopyran-4-carbamide was obtained. Next, 51.5 g of paratoluenesulfonyl chloride and 400 m of pyridine were added thereto, and the mixture was heated under reflux for 3 hours, and the solvent was distilled off. Ice water was added to the residue, the mixture was acidified with hydrochloric acid, and the precipitated crystals were collected by filtration, washed with water and dried. The crystals were subjected to silica gel chromatography (developing solution: CH 2 Cl 2 : hexane = 7:
Purified in 3), having a melting point of 162-164 ° C, represented by the following formula 4-
17.9 g of cyano-2,2-dimethyl-6-nitro-2H-1-benzopyran were obtained.

NMR(CDCl3):1.58(6H,s),6.51(1H,s),6.94(1H,
d),8.15(1H,dd),8.23(1H,d) MS:230(M+ 4−シアノ−2,2−ジメチル−6−ニトロ−2H−1−
ベンゾピラン13.0g、酢酸400m、水200m、濃硫酸100
mの混合物を1.5時間加熱還流した後、濃硫酸100m追
加し1時間加熱還流した。反応混合物を氷水中に注ぐと
結晶が折出した。この結晶を水洗乾燥後、アセトニトリ
ルと水の混合溶媒で再結晶して、融点203−204℃の下記
式で表される2,2−ジメチル−6−ニトロ−2H−1−ベ
ンゾピラン−4−カルボン酸11.9gを得た。
NMR (CDCl 3 ): 1.58 (6H, s), 6.51 (1H, s), 6.94 (1H,
d), 8.15 (1H, dd), 8.23 (1H, d) MS: 230 (M + ) 4-cyano-2,2-dimethyl-6-nitro-2H-1-
Benzopyran 13.0 g, acetic acid 400 m, water 200 m, concentrated sulfuric acid 100
After refluxing the mixture of 1.5 m for 1.5 hours, 100 m of concentrated sulfuric acid was added and the mixture was refluxed for 1 hour. When the reaction mixture was poured into ice water, crystals precipitated. The crystals are washed with water and dried, and then recrystallized with a mixed solvent of acetonitrile and water to give 2,2-dimethyl-6-nitro-2H-1-benzopyran-4-carboxylic acid having a melting point of 203-204 ° C and represented by the following formula. 11.9 g of the acid were obtained.

NMR(CDCl3−CD3OD):1.50(6H,s),6.80(1H,s),6.85
(1H,d),8.03(1H,dd),8.99(1H,d) MS:249(M+製造例31 6,6−ジメチル−6H−ピラノ〔2,3−f〕ベンゾ−2,1,3
−オキサジアゾール−8−カルボアミド 7,8−ジヒドロ−6,6−ジメチル−7,8−エポキシ−6H
−ピラノ〔2,3−f〕ベンゾ−2,1,3−オキサジアゾール
3.9gおよびトルエン80mの混合物に、氷冷攪拌下、1.0
Mジエチルアルミニウムシアニド90m(トルエン溶液)
を滴下し、室温で2時間攪拌した。反応混合物を氷水中
に注ぎ、2N−NaOHを加えメチレンクロライドで抽出し
た。有機層を水洗乾燥後、溶媒を留去し、シリカゲルカ
ラムクロマトグラフィー(展開液:CH2Cl2)で精製し
て、融点136−138℃の下記式で表される8−シアノ−6,
6−ジメチル−6H−ピラノ〔2,3−f〕ベンゾ−2,1,3−
オキサジアゾール2.9gを得た。
NMR (CDCl 3 -CD 3 OD) : 1.50 (6H, s), 6.80 (1H, s), 6.85
(1H, d), 8.03 (1H, dd), 8.99 (1H, d) MS: 249 (M + ) Production Example 31 6,6-dimethyl-6H-pyrano [2,3-f] benzo-2,1,3
-Oxadiazole-8-carbamide 7,8-dihydro-6,6-dimethyl-7,8-epoxy-6H
-Pyrano [2,3-f] benzo-2,1,3-oxadiazole
To a mixture of 3.9 g and toluene 80 m, under ice-cooling and stirring, 1.0
M diethylaluminum cyanide 90m (toluene solution)
Was added dropwise and stirred at room temperature for 2 hours. The reaction mixture was poured into ice water, 2N-NaOH was added, and the mixture was extracted with methylene chloride. The organic layer was washed with water and dried, and the solvent was distilled off. The residue was purified by silica gel column chromatography (developing solution: CH 2 Cl 2 ) to give 8-cyano-6 having a melting point of 136-138 ° C. and represented by the following formula.
6-dimethyl-6H-pyrano [2,3-f] benzo-2,1,3-
2.9 g of oxadiazole was obtained.

NMR(CDCl3):1.55(6H,s),6.83(1H,s),7.03(1H,
s),7.83(1H,s) MS:227(M+) IR(KBr):2232cm-1 8−シアノ−6,6−ジメチル−6H−ピラノ〔2,3−f〕
ベンゾ−2,1,3−オキサジアゾール0.66gおよび濃硫酸15
mの混合物を室温で、45時間攪拌した。反応混合物を
氷水中に注ぎ、エーテルで抽出した。有機層を水洗乾燥
後、溶媒を留去して得た残渣をシリカゲルカラムクロマ
トグラフィー(展開液:CH2Cl2:MeOH=99:1)で精製し、
酢酸エチルとヘキサンの混合溶液から再結晶して融点16
8−169℃の下記式で表される6,6−ジメチル−6H−ピラ
ノ〔2,3−f〕ベンゾ−2,1,3−オキサジアゾール−8−
カルボアミド0.35gを得た。
NMR (CDCl 3 ): 1.55 (6H, s), 6.83 (1H, s), 7.03 (1H,
s), 7.83 (1H, s) MS: 227 (M + ) IR (KBr): 2232 cm -1 8-cyano-6,6-dimethyl-6H-pyrano [2,3-f]
Benzo-2,1,3-oxadiazole 0.66 g and concentrated sulfuric acid 15
m mixture was stirred at room temperature for 45 hours. The reaction mixture was poured into ice water and extracted with ether. The organic layer was washed with water and dried, and the residue obtained by evaporating the solvent was purified by silica gel column chromatography (developing solution: CH 2 Cl 2 : MeOH = 99: 1).
Recrystallization from a mixed solution of ethyl acetate and hexane gave a melting point of 16
6,6-Dimethyl-6H-pyrano [2,3-f] benzo-2,1,3-oxadiazole-8- represented by the following formula at 8-169 ° C.
0.35 g of carboxamide was obtained.

NMR(CDCl3):1.52(6H,s),6.30(2H,br.s),6.60(1
H,s),7.07(1H,s),8.18(1H,s) MS:245(M+製造例32 6,6−ジメチル−6H−ピラノ〔2,3−f〕ベンゾ−2,1,3
−オキサジアゾール−8−カルボン酸 8−シサノ−6,6−ジメチル−6H−ピラノ〔2,3−f〕
ベンゾ−2,1,3−オキサジアゾール1.74g用い、上記製造
例30と同様に反応を行い融点246−248℃の下記式で表さ
れる6,6−ジメチル−6H−ピラノ〔2,3−f〕ベンゾ−2,
1,3−オキサジアゾール−8−カルボン酸1.76gを得た。
NMR (CDCl 3): 1.52 ( 6H, s), 6.30 (2H, br.s), 6.60 (1
H, s), 7.07 (1H, s), 8.18 (1H, s) MS: 245 (M + ) Production Example 32 6,6-Dimethyl-6H-pyrano [2,3-f] benzo-2,1,3
-Oxadiazole-8-carboxylic acid 8-cisano-6,6-dimethyl-6H-pyrano [2,3-f]
Using 1.74 g of benzo-2,1,3-oxadiazole, the reaction was carried out in the same manner as in Production Example 30, and the melting point was 246-248 ° C., and represented by the following formula, 6,6-dimethyl-6H-pyrano [2,3 -F] benzo-2,
1.76 g of 1,3-oxadiazole-8-carboxylic acid was obtained.

NMR(CD3OD):1.52(6H,s),7.07(1H,s),7.27(1H,
s),8.61(1H,s) MS:246(M+製造例33 N,2,2−トリメチル−6−アセチルアミド−2H−1−ベ
ンゾピラン−4−カルボアミド N,2,2−トリメチル−6−ニトロ−2H−1−ベンゾピ
ラン−4−カルボアミド1.55g、塩化第一錫3.84gおよび
乾燥エタノール30mの混合物を、4時間加熱還流し
た。溶媒を留去した後、無水酢酸15mを加え、室温で1
7時間攪拌した。反応液を減圧留去し、2N−塩酸を加え
酢酸エチルとエーテルの混合溶媒で抽出した。有機層を
水洗乾燥後、溶媒を留去して得た残渣をシリカゲルカラ
ムクロマトグラフィー(展開液:CH2Cl2:MeOH=99:1)で
精製して融点203−210℃の下記式で表されるN,2,2−ト
リメチル−6−アセチルアミド−2H−1−ベンゾピラン
−4−カルボアミド1.30gを得た。
NMR (CD 3 OD): 1.52 (6H, s), 7.07 (1H, s), 7.27 (1H,
s), 8.61 (1H, s) MS: 246 (M + ) Production Example 33 N, 2,2-trimethyl-6-acetylamido-2H-1-benzopyran-4-carbamide N, 2,2-trimethyl-6-nitro-2H-1-benzopyran-4-carbamide 1.55 g, chloride A mixture of 3.84 g of stannous and 30 m of dry ethanol was heated to reflux for 4 hours. After the solvent was distilled off, 15 m of acetic anhydride was added, and the mixture was added at room temperature for 1 hour.
Stir for 7 hours. The reaction solution was evaporated under reduced pressure, 2N-hydrochloric acid was added, and the mixture was extracted with a mixed solvent of ethyl acetate and ether. The organic layer is washed with water, dried and the solvent is distilled off. The residue obtained is purified by silica gel column chromatography (developing solution: CH 2 Cl 2 : MeOH = 99: 1), and expressed in the following formula with a melting point of 203-210 ° C. This gave 1.30 g of N, 2,2-trimethyl-6-acetylamido-2H-1-benzopyran-4-carbamide.

NMR(CDCl3−DMSO−d6):1.42(6H,s),2.06(3H,s),
2.85(3H,d),5.99(1H,s),6.74(1H,br.d),7.50(1
H,br.s),7.52(1H,s),7.60(1H,br.d),9.43(1H,br.
s) MS:274(M+製造例34 N,2,2−トリメチル−6−アセチルアミド−7−ニトロ
−2H−1−ベンゾピラン−4−カルボアミド N,2,2−トリメチル−6−アセチルアミド−2H−1−
ベンゾピラン−4−カルボアミド1.16gおよび酢酸15m
の混合物に、氷冷攪拌下、発煙硝酸0.50mを酢酸2m
に溶解したものを加え、室温で1時間攪拌した。氷水を
加え、酢酸エチルとエーテルの混合溶液で抽出した。有
機層を水洗乾燥後、溶媒を留去して得た残渣をシリカゲ
ルカラムクロマトグラフィー(展開液:CH2Cl2:MeOH=9
9:1)で精製して融点213−215℃の下記式で表されるN,
2,2−トリメチル−6−アセチルアミド−7−ニトロ−2
H−1−ベンゾピラン−4−カルボアミド0.55gを得た。
NMR (CDCl 3 -DMSO-d 6 ): 1.42 (6H, s), 2.06 (3H, s),
2.85 (3H, d), 5.99 (1H, s), 6.74 (1H, br.d), 7.50 (1
H, br.s), 7.52 (1H, s), 7.60 (1H, br.d), 9.43 (1H, br.
s) MS: 274 (M + ). Production Example 34 N, 2,2-trimethyl-6-acetylamido-7-nitro-2H-1-benzopyran-4-carbamide N, 2,2-trimethyl-6-acetylamido-2H-1-
Benzopyran-4-carbamide 1.16 g and acetic acid 15 m
To a mixture of the above, 0.50m of fuming nitric acid was added to 2m of acetic acid under ice-cooling and stirring.
Was added and stirred at room temperature for 1 hour. Ice water was added, and the mixture was extracted with a mixed solution of ethyl acetate and ether. The organic layer is washed with water and dried, and the residue obtained by evaporating the solvent is subjected to silica gel column chromatography (developing solution: CH 2 Cl 2 : MeOH = 9).
9: 1) and purified by melting point 213-215 ° C.
2,2-trimethyl-6-acetylamido-7-nitro-2
0.55 g of H-1-benzopyran-4-carbamide was obtained.

NMR(CDCl3):1.45(6H,s),2.23(3H,s),2.96(3H,
d),6.25(1H,br.s),6.29(1H,s),7.59(1H,s),8.66
(1H,s),9.92(1H,br.s) MS:319(M+製造例35 N,2,2−トリメチル−6−アミノ−7−ニトロ−2H−1
−ベンゾピラン−4−カルボアミド N,2,2−トリメチル−6−アセチルアミド−7−ニト
ロ−2H−1−ベンゾピラン−4−カルボアミド0.50g、
エタノール15mおよび2N−水酸化ナトリウムの混合物
を、室温で3時間攪拌した。飽和食塩水を加えエーテル
で抽出した。有機層を飽和食塩水で洗い、乾燥し、溶媒
を留去すると融点202−205℃の下記式で表されるN,2,2
−トリメチル−6−アミノ−7−ニトロ−2H−1−ベン
ゾピラン−4−カルボアミド0.40gを得た。
NMR (CDCl 3 ): 1.45 (6H, s), 2.23 (3H, s), 2.96 (3H,
d), 6.25 (1H, br.s), 6.29 (1H, s), 7.59 (1H, s), 8.66
(1H, s), 9.92 (1H, br.s) MS: 319 (M + ) Production Example 35 N, 2,2-Trimethyl-6-amino-7-nitro-2H-1
-Benzopyran-4-carbamide N, 2,2-trimethyl-6-acetylamido-7-nitro-2H-1-benzopyran-4-carbamide 0.50 g,
A mixture of 15m of ethanol and 2N-sodium hydroxide was stirred at room temperature for 3 hours. Saturated saline was added and extracted with ether. The organic layer was washed with a saturated saline solution, dried, and the solvent was distilled off.N, 2,2 having a melting point of 202-205 ° C and represented by the following formula:
0.40 g of -trimethyl-6-amino-7-nitro-2H-1-benzopyran-4-carbamide were obtained.

NMR(CDCl3):1.43(6H,s),2.93(3H,d),5.91(3H,b
r.s),6.20(1H,s),7.13(1H,s),7.52(1H,s) MS:277(M+製造例36 N−シアノ−N′,N′−ジメチル−6−ニトロスピロ
〔2H−1−ベンゾピラン−2,1′−シクロブタン〕−4
−アミジン N,N′−ジメチル−6−ニトロスピロ〔2H−1−ベン
ゾピラン−2,1′−シクロブタン〕−4−カルボチオア
ミド0.08g、ヨードメタン0.42g、シアナミド0.08gおよ
び乾燥テトラヒドロフラン4mの混合物に、氷冷攪拌
下、ナトリウムハイドライド(60%)0.08g加え、室温
で12時間攪拌した後、40℃で30分攪拌した。氷水を加え
メチレンクロライドで抽出した。有機層を水洗乾燥後、
溶媒を留去して得た残渣をシリカゲルカラムクロマトグ
ラフィー(展開液:CH2Cl2:MeOH=99:1)で精製し、酢酸
エチルとヘキサンの混合溶媒から再結晶して融点185−1
87℃の下記式で表されるN−シアノ−N,N′−ジメチル
−6−ニトロスピロ〔2H−1−ベンゾピラン−2,1′−
シクロブタン〕−4−アミジン0.06gを得た。
NMR (CDCl 3): 1.43 ( 6H, s), 2.93 (3H, d), 5.91 (3H, b
rs), 6.20 (1H, s), 7.13 (1H, s), 7.52 (1H, s) MS: 277 (M + ) Production Example 36 N-cyano-N ', N'-dimethyl-6-nitrospiro [2H-1-benzopyran-2,1'-cyclobutane] -4
-Amidine N, N'-dimethyl-6-nitrospiro [2H-1-benzopyran-2,1'-cyclobutane] -4-carbothioamide 0.08 g, iodomethane 0.42 g, cyanamide 0.08 g and dry tetrahydrofuran 4m in a mixture of ice, Under cold stirring, 0.08 g of sodium hydride (60%) was added, and the mixture was stirred at room temperature for 12 hours and then at 40 ° C for 30 minutes. Ice water was added and extracted with methylene chloride. After washing the organic layer with water and drying,
The residue obtained by distilling off the solvent was purified by silica gel column chromatography (developing solution: CH 2 Cl 2 : MeOH = 99: 1), and recrystallized from a mixed solvent of ethyl acetate and hexane to give a melting point of 185-1.
At 87 ° C., N-cyano-N, N′-dimethyl-6-nitrospiro [2H-1-benzopyran-2,1′-
Cyclobutane] -4-amidine 0.06 g was obtained.

NMR(CDCl3):1.56−2.88(6H,m),3.00(3H,s),3.24
(3H,s),6.25(1H,s),6.88(1H,d),7.56(1H,d),8.
01(1H,dd). MS:312(M+製造例37 N−シアノ−N′−メチル−6−ニトロスピロ〔2H−1
−ベンゾピラン−2,1′−シクロヘキサン〕−4−アミ
ジン N−メチル−6−ニトロ−スピロ〔2H−1−ベンゾピ
ラン−2,1′−シクロヘキサン〕−4−カルボチオアミ
ド120mg、ヨードエタン150μlおよび乾燥テトラヒドロ
フラン3mの混合物に、氷冷攪拌下、ナトリウムハイド
ライド(60%)23mg加え、2時間加熱還流した。室温ま
で冷却後、シアナミド80mgおよびナトリウムハイドライ
ド(60%)17mg加え、4時間加熱還流した。氷水を加え
酢酸エチルで抽出した。有機層を水洗乾燥後、溶媒を留
去して得た残渣をシリカゲルカラムクロマトグラフィー
(展開液:酢酸エチルエステル:ヘキサン=2:3)で精
製し、酢酸エチルエステルとヘキサンの混合溶媒から再
結晶して融点244−245℃の下記式で表されるN−シアノ
−N′−メチル−6−ニトロスピロ〔2H−1−ベンゾピ
ラン−2,1′−シクロヘキサン〕−4−アミジン90mgを
得た。
NMR (CDCl 3): 1.56-2.88 ( 6H, m), 3.00 (3H, s), 3.24
(3H, s), 6.25 (1H, s), 6.88 (1H, d), 7.56 (1H, d), 8.
01 (1H, dd). MS: 312 (M + ) Production Example 37 N-cyano-N'-methyl-6-nitrospiro [2H-1
-Benzopyran-2,1'-cyclohexane] -4-amidine N-methyl-6-nitro-spiro [2H-1-benzopyran-2,1'-cyclohexane] -4-carbothioamide 120 mg, iodoethane 150 μl and dry tetrahydrofuran 3 m To the mixture was added 23 mg of sodium hydride (60%) with stirring under ice-cooling, and the mixture was heated under reflux for 2 hours. After cooling to room temperature, 80 mg of cyanamide and 17 mg of sodium hydride (60%) were added, and the mixture was heated under reflux for 4 hours. Ice water was added and extracted with ethyl acetate. The organic layer is washed with water and dried, and the residue obtained by evaporating the solvent is purified by silica gel column chromatography (developing solution: ethyl acetate: hexane = 2: 3) and recrystallized from a mixed solvent of ethyl acetate and hexane. As a result, 90 mg of N-cyano-N'-methyl-6-nitrospiro [2H-1-benzopyran-2,1'-cyclohexane] -4-amidine represented by the following formula and having a melting point of 244-245 ° C. was obtained.

NMR(CDCl3−CD3OD):1.40−2.20(10H,m),2.95(3H,
d),5.95(1H,s),6.85(1H,d),7.75(1H,d),8.00(1
H,dd) MS:326(M+製造例38 N−(2−シアノエチル)−6−ニトロスピロ〔2H−1
−ベンゾピラン−2,1′−シクロヘキサン〕−4−カル
ボアミド 6−ニトロスピロ〔2H−1−ベンゾピラン−2,1′−
シクロヘキサン〕−4−カルボン酸500mgおよびテトラ
ヒドロフラン7mの混合物に氷冷攪拌下、カルボニルジ
イミダゾール365mgを加え1.5時間攪拌した後、2−シア
ノエチルアミン0.37mのテトラヒドロフラン溶液3.5m
を加え、氷冷下45分間攪拌した。炭酸カリウム水溶液
を加えメチレンクロライドで抽出した。有機層を水洗乾
燥後、溶媒を留去して得た残渣をシリカゲルカラムクロ
マトグラフィー(展開液:MeOH:CH2Cl2=1:99)で精製
し、酢酸エチルとヘキサンの混合溶媒から再結晶して融
点122−124℃の下記式で表されるN−(2−シアノエチ
ル)−6−ニトロスピロ〔2H−1−ベンゾピラン−2,
1′−シクロヘキサン〕−4−カルボアミド402.6mgを得
た。
NMR (CDCl 3 -CD 3 OD) : 1.40-2.20 (10H, m), 2.95 (3H,
d), 5.95 (1H, s), 6.85 (1H, d), 7.75 (1H, d), 8.00 (1
H, dd) MS: 326 (M + ) Production Example 38 N- (2-cyanoethyl) -6-nitrospiro [2H-1
-Benzopyran-2,1'-cyclohexane] -4-carbamide 6-nitrospiro [2H-1-benzopyran-2,1'-
To a mixture of 500 mg of (cyclohexane) -4-carboxylic acid and 7 m of tetrahydrofuran, 365 mg of carbonyldiimidazole was added under ice-cooling and stirring, and the mixture was stirred for 1.5 hours, and then a solution of 0.37 m of 2-cyanoethylamine in 3.5 m of tetrahydrofuran was added.
Was added and the mixture was stirred under ice cooling for 45 minutes. An aqueous potassium carbonate solution was added, and the mixture was extracted with methylene chloride. The organic layer is washed with water and dried, and the residue obtained by evaporating the solvent is purified by silica gel column chromatography (developing solution: MeOH: CH 2 Cl 2 = 1: 99) and recrystallized from a mixed solvent of ethyl acetate and hexane. N- (2-cyanoethyl) -6-nitrospiro [2H-1-benzopyran-2, having a melting point of 122-124 ° C.
12.6 g of 1'-cyclohexane] -4-carbamide were obtained.

NMR(CDCl3)δ:0.89−2.32(10H,m),2.71(2H,t),3.
61(2H,q),6.11(1H,s),6.78(1H,d),7.26(1H,t),
7.89(1H,dd),8.36(1H,d). MS m/z:341(M+製造例39 2,2−ビスフルオロメチル−N−メチル−6−ニトロ−2
H−1−ベンゾピラン−4−カルボチオアミド 2,2−ビスフルオロメチル−N−メチル−6−ニトロ
−2H−1−ベンゾピラン−4−カルボアミド0.08g、ロ
ーソン試薬0.06g及びベンゼン2mの混合物を1時間加
熱還流した。溶媒を留去して得た残渣をシリカゲルカラ
ムクロマトグラフィー(展開液:CH2Cl2)で精製し、さ
らに酢酸エチルとヘキサンの混合溶媒で再結晶して融点
134−135℃の下記式で表される2,2−ビスフルオロメチ
ル−N−メチル−6−ニトロ−2H−1−ベンゾピラン−
4−カルボチオアミド71mgを得た。
NMR (CDCl 3) δ: 0.89-2.32 (10H, m), 2.71 (2H, t), 3.
61 (2H, q), 6.11 (1H, s), 6.78 (1H, d), 7.26 (1H, t),
7.89 (1H, dd), 8.36 (1H, d). MS m / z: 341 (M + ) Production Example 39 2,2-Bisfluoromethyl-N-methyl-6-nitro-2
H-1-benzopyran-4-carbothioamide A mixture of 2,2-bisfluoromethyl-N-methyl-6-nitro-2H-1-benzopyran-4-carbamide 0.08 g, Lawesson's reagent 0.06 g, and benzene 2 m for 1 hour Heated to reflux. The residue obtained by distilling off the solvent was purified by silica gel column chromatography (developing solution: CH 2 Cl 2 ), and further recrystallized with a mixed solvent of ethyl acetate and hexane to give a melting point.
2,2-bisfluoromethyl-N-methyl-6-nitro-2H-1-benzopyran- represented by the following formula at 134-135 ° C.
71 mg of 4-carbothioamide were obtained.

NMR(CDCl3)δ:3.30(3H,d),4.60(4H,d),5.85(1H,
d),6.98(1H,d),7.97(1H,brs),8.07(1H,dd),8.37
(1H,d). MS m/z:314(M+製造例40 2,2−ビスフルオロメチル−N−メチル−6−ニトロ−2
H−1−ベンゾピラン−4−カルボアミド (1)2,2−ビスフルオロメチル−3,4−ジヒドロ−6−
ニトロ−2H−1−ベンゾピラン−4−オン4.05g及び乾
燥ベンゼン10mの混合物に、氷冷下で攪拌しながら、
トリメチルシリルシアニド2.52mを加え、ヨウ化亜鉛
0.82gを加え、室温で12時間攪拌した。さらに、ピリジ
ン8mとオキシ塩化リン4.41mを加え、6時間加熱還
流した。残渣を氷水を加え、塩酸性にしてメチレンクロ
ライドで抽出した。有機層を水洗乾燥後、溶媒を留去し
て得た残渣をシリカゲルカラムクロマトグラフィー(展
開液:CH2Cl2:ヘキサン=7:3)で精製して融点136−137
℃の4−シアノ−2,2−ビスフルオロメチル−6−ニト
ロ−2H−1−ベンゾピラン0.99gを得た。
NMR (CDCl 3 ) δ: 3.30 (3H, d), 4.60 (4H, d), 5.85 (1H,
d), 6.98 (1H, d), 7.97 (1H, brs), 8.07 (1H, dd), 8.37
(1H, d). MS m / z: 314 (M + ) Production Example 40 2,2-Bisfluoromethyl-N-methyl-6-nitro-2
H-1-benzopyran-4-carbamide (1) 2,2-bisfluoromethyl-3,4-dihydro-6
To a mixture of 4.05 g of nitro-2H-1-benzopyran-4-one and 10 m of dry benzene, while stirring under ice-cooling,
Add 2.52m of trimethylsilyl cyanide, add zinc iodide
0.82 g was added, and the mixture was stirred at room temperature for 12 hours. Further, 8 m of pyridine and 4.41 m of phosphorus oxychloride were added, and the mixture was heated under reflux for 6 hours. Ice water was added to the residue to make it hydrochloric acid and extracted with methylene chloride. The organic layer was washed with water and dried, and the residue obtained by evaporating the solvent was purified by silica gel column chromatography (eluent: CH 2 Cl 2 : hexane = 7: 3) to give a melting point of 136-137.
0.99 g of 4-cyano-2,2-bisfluoromethyl-6-nitro-2H-1-benzopyran at <RTIgt;

NMR(CDCl3)δ:4.57(4H,d),6.50(1H,s),6.97(2H,
dd),8.14(2H,dd),8.23(1H,s) MS m/z:266(M+) (2)4−シアノ−2,2−ビスフルオロメチル−6−ニ
トロ−2H−1−ベンゾピラン0.93g、酢酸20m、水10m
、濃硫酸10mの混合物を4.5時間加熱還流した。反応
混合物を氷水中に注ぐと結晶が析出した。この結晶を重
曹水で溶解してメチレンクロライドで洗った。水層を塩
酸酸性にし、メチレンクロライドで抽出した。有機層を
水洗乾燥後、溶媒を留去して融点171−172℃の2,2−ビ
スフルオロメチル−6−ニトロ−2H−1−ベンゾピラン
−4−カルボン酸0.83gを得た。
NMR (CDCl 3 ) δ: 4.57 (4H, d), 6.50 (1H, s), 6.97 (2H,
dd), 8.14 (2H, dd), 8.23 (1H, s) MS m / z: 266 (M + ) (2) 4-cyano-2,2-bisfluoromethyl-6-nitro-2H-1-benzopyran 0.93g, acetic acid 20m, water 10m
And a mixture of concentrated sulfuric acid (10 m) was heated to reflux for 4.5 hours. When the reaction mixture was poured into ice water, crystals precipitated. The crystals were dissolved in aqueous sodium hydrogen carbonate and washed with methylene chloride. The aqueous layer was acidified with hydrochloric acid and extracted with methylene chloride. After the organic layer was washed with water and dried, the solvent was distilled off to obtain 0.83 g of 2,2-bisfluoromethyl-6-nitro-2H-1-benzopyran-4-carboxylic acid having a melting point of 171-172 ° C.

IR(KBr)cm-1:1698(C=0). MS m/z:285(M+) (3)2,2−ビスフルオロメチル−6−ニトロ−2H−1
−ベンゾピラン−4−カルボン酸0.78g及びテトラヒド
ロフラン5mの混合物を氷冷攪拌下、カルボニルジイミ
ダゾール0.67gを加え1時間攪拌した。その後、40%メ
チルアミン(メタノール溶液)6.3mを加え、氷冷下1
時間攪拌し、次いで室温で14時間攪拌した。炭酸カリウ
ム水溶液を加えエーテルで抽出した。有機層を水洗乾燥
後、溶媒を留去して得た残渣をシリカゲルカラムクロマ
トグラフィー(展開液:MeOH:CH2Cl2=1:99で精製して融
点178−179℃の下記式で表される2,2−ビスフルオロメ
チル−N−メチル−6−ニトロ−2H−1−ベンゾピラン
−4−カルボアミド0.13gを得た。
IR (KBr) cm -1 : 1698 (C = 0). MS m / z: 285 (M + ) (3) 2,2-bisfluoromethyl-6-nitro-2H-1
A mixture of 0.78 g of -benzopyran-4-carboxylic acid and 5 m of tetrahydrofuran was added with 0.67 g of carbonyldiimidazole under ice cooling and stirring, followed by stirring for 1 hour. Thereafter, 6.3 m of 40% methylamine (methanol solution) was added, and the mixture was added under ice cooling for 1 hour.
And then stirred at room temperature for 14 hours. An aqueous potassium carbonate solution was added, and the mixture was extracted with ether. The organic layer is washed with water and dried, and the residue obtained by evaporating the solvent is purified by silica gel column chromatography (developing solution: MeOH: CH 2 Cl 2 = 1: 99 and expressed by the following formula having a melting point of 178-179 ° C. This gave 0.13 g of 2,2-bisfluoromethyl-N-methyl-6-nitro-2H-1-benzopyran-4-carbamide.

NMR(CDCl3)δ:2.80(3H,d),4.68(4H,d),6.21(1H,
s),7.08(1H,d),8.10(1H,dd),8.46(1H,brs),8.48
(1H,d). MS m/z:298(M+製造例41 N−(2−シアノエチル)−6−ニトロ−2,2−ジメチ
ル−2H−1−ベンゾピラン−4−カルボチオアミド N−(2−シアノエチル)−6−ニトロ−2,2−ジメ
チル−2H−1−ベンゾピラン−4−カルボアミド0.40
g、ローソン試薬0.28gおよびベンゼン2mの混合液を1
時間30分加熱還流後、シリカゲルカラムクロマトグラフ
ィー(CH2CH2)で精製し、さらにジエチルエーテルおよ
びn−ヘキサンの混合液で再結晶し融点116−118℃の下
記式で示されるN−(2−シアノエチル)−6−ニトロ
−2,2−ジメチル−2H−1−ベンゾピラン−4−カルボ
チオアミド0.24gを得た。
NMR (CDCl 3 ) δ: 2.80 (3H, d), 4.68 (4H, d), 6.21 (1H,
s), 7.08 (1H, d), 8.10 (1H, dd), 8.46 (1H, brs), 8.48
(1H, d). MS m / z: 298 (M + ) Production Example 41 N- (2-cyanoethyl) -6-nitro-2,2-dimethyl-2H-1-benzopyran-4-carbothioamide N- (2-cyanoethyl) -6-nitro-2,2-dimethyl-2H -1-benzopyran-4-carbamide 0.40
g, Lawson's reagent 0.28g and benzene 2m
After heating and refluxing for 30 minutes, the mixture was purified by silica gel column chromatography (CH 2 CH 2 ), and further recrystallized from a mixture of diethyl ether and n-hexane to give N- (2 -Cyanoethyl) -6-nitro-2,2-dimethyl-2H-1-benzopyran-4-carbothioamide was obtained in an amount of 0.24 g.

NMR(CDCl3):1.5(6H,s),2.9(2H,t),4.05(2H,t),
5.9(1H,s),6.85(1H,d),8.0(1H,dd),8.3(1H,d),
8.0−8.6(1H,m). MS:317(M製造例42 N−(2−シアノエチル)−2,2−ビスフルオロメチル
−6−ニトロ−2H−ベンゾピラン−4−カルボアミド 2,2−ビスフルオロメチル−6−ニトロ−2H−1−ベ
ンゾピラン−4−カルボン酸30mg及びテトラヒドロフラ
ン2mの混合物に氷冷攪拌下、カルボニルイミダゾール
28mgを加え1時間攪拌した。その後、2−シアノエチル
アミン0.10mを加え、氷冷下1時間攪拌し、次いで室
温で12時間攪拌した。炭酸カリウム水溶液を加えメチレ
ンクロライドで抽出した。有機層を水洗乾燥後、溶媒を
留去して得た残渣を酢酸エチルとヘキサンの混合溶媒で
再結晶して融点173−174℃の下記式で表されるN−(2
−シアノエチル)−2,2−ビスフルオロメチル−6−ニ
トロ−2H−1−ベンゾピラン−4−カルボアミド26.6mg
を得た。
NMR (CDCl 3 ): 1.5 (6H, s), 2.9 (2H, t), 4.05 (2H, t),
5.9 (1H, s), 6.85 (1H, d), 8.0 (1H, dd), 8.3 (1H, d),
8.0-8.6 (1H, m). MS: 317 (M * ) Production Example 42 N- (2-cyanoethyl) -2,2-bisfluoromethyl-6-nitro-2H-benzopyran-4-carbamide 2,2-bisfluoromethyl-6-nitro-2H-1-benzopyran-4- To a mixture of 30 mg of carboxylic acid and 2 m of tetrahydrofuran, carbonylimidazole was added while stirring on ice.
28 mg was added and the mixture was stirred for 1 hour. Thereafter, 0.10 m of 2-cyanoethylamine was added, and the mixture was stirred under ice cooling for 1 hour, and then stirred at room temperature for 12 hours. An aqueous potassium carbonate solution was added, and the mixture was extracted with methylene chloride. The organic layer is washed with water and dried, and the residue obtained by evaporating the solvent is recrystallized with a mixed solvent of ethyl acetate and hexane to give N- (2) having a melting point of 173-174 ° C and represented by the following formula.
-Cyanoethyl) -2,2-bisfluoromethyl-6-nitro-2H-1-benzopyran-4-carbamide 26.6 mg
I got

NMR(CDCl3−CF3COOD)δ:2.89(2H,t),3.81(2H,t),
4.61(4H,d),6.24(1H,s),7.05(1H,d),8.15(1H,
d),8.29(1H,d) MS m/z:337(M+製造例43〜255 上記実施例に記載した方法を用いて以下の表に示す化
合物を合成した。
NMR (CDCl 3 -CF 3 COOD) δ: 2.89 (2H, t), 3.81 (2H, t),
4.61 (4H, d), 6.24 (1H, s), 7.05 (1H, d), 8.15 (1H,
d), 8.29 (1H, d) MS m / z: 337 (M + ). Production Examples 43 to 255 The compounds shown in the following table were synthesized using the methods described in the above Examples.

次に、実施例を挙げて、本発明の発毛促進剤の効果に
ついて説明するが、本発明の範囲はかなり実施例によっ
て制限されるものではない。
Next, the effects of the hair growth promoting agent of the present invention will be described with reference to examples, but the scope of the present invention is not significantly limited by the examples.

実施例 C3H系マウスによる発毛促進実験 毛周期が休止期にあるC3H/HeNマウス(雄)を用い、
小川らの方法(“Normal and Abnormal Epidermal Diff
erentiation",M.Seiji and A.Bernstein編集、159−170
頁、1982年、東大出版会)により実験を行なった。
Example Hair growth promotion experiment using C3H mice Using C3H / HeN mice (male) whose hair cycle is in telogen,
Ogawa et al.'S method (“Normal and Abnormal Epidermal Diff
erentiation ", edited by M. Seiji and A. Bernstein, 159-170
Page, 1982, University of Tokyo Press).

すなわち、生後7週齢のC3H/HeNマウス(雄)を購入
し、2週間予備飼育後、10匹を1グループとし、薬剤塗
布日の3日前の2日間、2回、バリカンおよびシェーバ
ーにてマウスの背部を剃毛した。1日おいてから、本発
明に係る化合物のエタノール溶液(0.0003〜1%)を1
日1回、100μ/匹、ピペットにて塗布投与した。別
のグループにはコントロールとしてエタノールのみを塗
布投与し、さらに別のグループには比較のためミノキシ
ジールのエタノール溶液(0.1〜1%)を塗布投与し
た。塗布投与から所定の日数経過後に発毛部分の面積を
測定し、マウス背部の除毛部の面積を100%とするとき
の発毛率(%)を算出した。本発明に係る化合物とし
て、化合物3、8、10、11、14、38、39、40、41、42、
87、88、89、92、94、103、108、109、131、133、135、
187、190、191、195、275、282、293、302を用いた。結
果は図1〜19に示すとおりであった。なお、図2および
図4において、それぞれ化合物3および化合物8を塗布
投与した場合の14日経過時のマウスの様子を写真で示し
た。
That is, C3H / HeN mice (male) at the age of 7 weeks old were purchased and preliminarily reared for 2 weeks, and 10 mice were grouped as a group. The back was shaved. After one day, an ethanol solution (0.0003 to 1%) of the compound of the present invention is added for 1 day.
Once a day, 100 μ / animal was applied and administered with a pipette. Another group was applied with ethanol alone as a control, and another group was applied with an ethanol solution of minoxidil (0.1-1%) for comparison. The area of the hair growth portion was measured a predetermined number of days after application and administration, and the hair growth rate (%) was calculated assuming that the area of the hair removal portion on the back of the mouse was 100%. As the compound according to the present invention, compounds 3, 8, 10, 11, 14, 38, 39, 40, 41, 42,
87, 88, 89, 92, 94, 103, 108, 109, 131, 133, 135,
187, 190, 191, 195, 275, 282, 293, 302 were used. The results were as shown in FIGS. 2 and 4 show photographs of the mice 14 days after the application of Compound 3 and Compound 8, respectively.

産業上の利用可能性 図1〜19から明らかなように、ベンゾピラン誘導体を
含有する本発明の発毛促進剤はミノキシジールよりもか
なり高い発毛促進効果を示す。したがって、本発明の発
毛促進剤は、男性型脱毛症のみならず、円形脱毛症・分
娩後脱毛症、抗ガン剤による脱毛症の治療および予防に
有用である。
INDUSTRIAL APPLICABILITY As is apparent from FIGS. 1 to 19, the hair growth promoter of the present invention containing a benzopyran derivative shows a considerably higher hair growth promoting effect than minoxidil. Therefore, the hair growth-promoting agent of the present invention is useful for treating and preventing alopecia areata, postpartum alopecia, and alopecia with anticancer agents, as well as male pattern baldness.

───────────────────────────────────────────────────── フロントページの続き (56)参考文献 特開 昭63−303977(JP,A) 特開 昭51−57838(JP,A) 特開 平2−273610(JP,A) 特開 平5−43432(JP,A) 特開 昭55−85582(JP,A) 特表 平2−500272(JP,A) (58)調査した分野(Int.Cl.7,DB名) A61K 7/06 C07D 311/58 CA(STN) REGISTRY(STN)──────────────────────────────────────────────────続 き Continuation of front page (56) References JP-A-63-303977 (JP, A) JP-A-51-57838 (JP, A) JP-A-2-273610 (JP, A) JP-A-5-273 43432 (JP, A) JP-A-55-85582 (JP, A) Japanese Translation of PCT Application No. Hei 2-500272 (JP, A) (58) Fields investigated (Int. Cl. 7 , DB name) A61K 7/06 C07D 311 / 58 CA (STN) REGISTRY (STN)

Claims (5)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】一般式 (式中、Xは=O,=S,=N−Z又は=CHNO2を示し、こ
こでZは水素原子、低級アルキル基、アリール基、水酸
基、低級アルコキシ基、シアノ基、カルバモイル基又は
スルファモイル基を示す; Yは−NR8R9、−OR10又は−SR11を、ここでR8及びR9
同一又は異なって水素原子、水酸基、エチニル基で置換
されていてもよい低級アルコキシ基、シアノ基、置換基
を有していてもよいアミノ基、置換基を有していてもよ
い低級アルキル基、置換基を有していてもよい不飽和低
級アルキル基、置換基を有していてもよいシクロアルキ
ル基、置換基を有していてもよいアリール基、置換基を
有していてもよいヘテロアリール基を示すか、又はR8
びR9は一緒になって窒素原子と共に、置換基を有してい
てもよい複素環であってアジリジニル基、アゼチジニル
基、ピロリジニル基、ピペリジニル基、ピペラジル基、
モルホリノ基およびイミダゾリル基から選ばれる複素環
を示し、R10及びR11は水素原子、低級アルキル基又はア
リール基を示す。ここで置換基は、ハロゲン原子、低級
アルキル基、低級アルコキシ基、アミノ基、ニトロ基、
低級ハロアルキル基、低級ハロアルコキシ基、シアノ
基、ヒドロキシ基、低級アルコキシカルボニルアミノ
基、フェニル基、低級アルコキシカルボニル基、トリア
ルキルシリル基、トリアルキルシリルオキシ基、アミノ
カルボニル基、エチニル基、低級アルキルアミノ基、低
級アルキルチオ基および低級アルキルカルボニル基から
選ばれる1以上の基を示す。ただし、R8及びR9が低級ア
ルキル基のときは、該置換基としての低級アルキル基を
除かれる。; R1は水素原子、低級アルキル基又はアリール基を示す
か、又はR2と直接結合して単結合を形成する: R2及びR3は同一又は異なって水素原子若しくは水酸基を
示すか、又は一緒になって=Oを形成するか、あるいは
R2はR1と直接結合して単結合を形成する; R4及びR5は、同一又は異なって水素原子、置換基を有し
ていてもよい低級アルキル基を示すか、一緒になってポ
リメチレン基を示す。ここで置換基は、ハロゲン原子、
低級アルコキシ基、アミノ基、ニトロ基、低級ハロアル
キル基、低級ハロアルコキシ基およびシアノ基から選ば
れる1以上の基を示す。; R6及びR7は、同一又は異なって水素原子、低級アルキル
基、低級ハロアルキル基、ハロゲン原子、低級アルコキ
シ基、低級ハロアルコキシ基、アミノ基、アシルアミノ
基、ニトロ基、シアノ基、エステル基、低級アルキルス
ルホニル基又はアリールスルホニル基を示すか、又は一
緒になって=N−O−N=を示す) で表されるベンゾピラン誘導体、またはその医薬上許容
される塩を一種または二種以上含有して成ることを特徴
とする発毛促進剤。
(1) General formula (Wherein X represents OO,, S, NNZ or CHCHNO 2 , wherein Z is a hydrogen atom, a lower alkyl group, an aryl group, a hydroxyl group, a lower alkoxy group, a cyano group, a carbamoyl group or a sulfamoyl group. Y represents -NR 8 R 9 , -OR 10 or -SR 11 , wherein R 8 and R 9 are the same or different and may be a lower alkoxy group optionally substituted by a hydrogen atom, a hydroxyl group or an ethynyl group; A cyano group, an amino group which may have a substituent, a lower alkyl group which may have a substituent, an unsaturated lower alkyl group which may have a substituent, May represent a cycloalkyl group, an aryl group optionally having a substituent, a heteroaryl group optionally having a substituent, or R 8 and R 9 together with a nitrogen atom, A heterocyclic ring which may have a substituent, such as an aziridinyl group, Group, a pyrrolidinyl group, a piperidinyl group, piperazyl group,
It represents a heterocyclic ring selected from a morpholino group and an imidazolyl group, and R 10 and R 11 represent a hydrogen atom, a lower alkyl group or an aryl group. Here, the substituent is a halogen atom, a lower alkyl group, a lower alkoxy group, an amino group, a nitro group,
Lower haloalkyl group, lower haloalkoxy group, cyano group, hydroxy group, lower alkoxycarbonylamino group, phenyl group, lower alkoxycarbonyl group, trialkylsilyl group, trialkylsilyloxy group, aminocarbonyl group, ethynyl group, lower alkylamino And represents one or more groups selected from a group, a lower alkylthio group and a lower alkylcarbonyl group. However, when R 8 and R 9 are a lower alkyl group, the lower alkyl group as the substituent is excluded. ; Or R 1 represents a hydrogen atom, a lower alkyl group or an aryl group, or forms a single bond directly bonded to the R 2: R 2 and R 3 represents a hydrogen atom or a hydroxyl group the same or different, or Together to form = O, or
R 2 is directly bonded to R 1 to form a single bond; R 4 and R 5 are the same or different and represent a hydrogen atom, a lower alkyl group which may have a substituent, or taken together; Indicates a polymethylene group. Here, the substituent is a halogen atom,
And at least one group selected from a lower alkoxy group, an amino group, a nitro group, a lower haloalkyl group, a lower haloalkoxy group and a cyano group. R 6 and R 7 are the same or different and are a hydrogen atom, a lower alkyl group, a lower haloalkyl group, a halogen atom, a lower alkoxy group, a lower haloalkoxy group, an amino group, an acylamino group, a nitro group, a cyano group, an ester group, A lower alkylsulfonyl group or an arylsulfonyl group, or together form = N-ON =), or one or more pharmaceutically acceptable salts thereof. A hair growth promoting agent comprising:
【請求項2】R1とR2が直接結合して単結合を形成してお
り、R3が水素原子であるベンゾピラン誘導体またはその
医薬上許容される塩を含有する請求項1の発毛促進剤。
2. The hair growth promoting method according to claim 1, wherein R 1 and R 2 are directly bonded to form a single bond, and the benzopyran derivative or a pharmaceutically acceptable salt thereof wherein R 3 is a hydrogen atom is contained. Agent.
【請求項3】R4及びR5が、同一または異なって、ハロゲ
ン原子、低級アルコキシ基、アミノ基、ニトロ基、低級
ハロアルキル基、低級ハロアルコキシ基およびシアノ基
から選ばれる1以上の置換基を有していてもよい低級ア
ルキル基であるか、又は一緒になってポリメチレン基を
形成するベンゾピラン誘導体またはその医薬上許容され
る塩を含有する請求項1の発毛促進剤。
3. R 4 and R 5 are the same or different and each represents one or more substituents selected from a halogen atom, a lower alkoxy group, an amino group, a nitro group, a lower haloalkyl group, a lower haloalkoxy group and a cyano group. The hair growth promoting agent according to claim 1, which contains a benzopyran derivative or a pharmaceutically acceptable salt thereof, which is a lower alkyl group which may be present or forms a polymethylene group together.
【請求項4】R6が6−ニトロ基であるベンゾピラン誘導
体またはその医薬上許容される塩を含有する請求項1の
発毛促進剤。
4. The hair growth-promoting agent according to claim 1, which comprises a benzopyran derivative wherein R 6 is a 6-nitro group or a pharmaceutically acceptable salt thereof.
【請求項5】Yが−NR8R9であるベンゾピラン誘導体ま
たはその医薬上許容される塩を含有する請求項1の発毛
促進剤。
5. The hair growth-promoting agent according to claim 1, comprising a benzopyran derivative wherein Y is -NR 8 R 9 or a pharmaceutically acceptable salt thereof.
JP50508292A 1991-02-18 1992-02-17 Hair growth promoter Expired - Fee Related JP3255411B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP3-45744 1991-02-18
JP4574491 1991-02-18
PCT/JP1992/000154 WO1992014439A1 (en) 1991-02-18 1992-02-17 Hair growth stimulant

Publications (1)

Publication Number Publication Date
JP3255411B2 true JP3255411B2 (en) 2002-02-12

Family

ID=12727831

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50508292A Expired - Fee Related JP3255411B2 (en) 1991-02-18 1992-02-17 Hair growth promoter

Country Status (4)

Country Link
JP (1) JP3255411B2 (en)
AU (1) AU1256192A (en)
TW (1) TW260665B (en)
WO (1) WO1992014439A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994025021A1 (en) * 1993-04-23 1994-11-10 Chugai Seiyaku Kabushiki Kaisha Benzopyran derivative
US5470861A (en) * 1994-08-04 1995-11-28 Hoffmann-La Roche Inc. Method of promoting hair growth
JP2001278873A (en) * 2000-03-27 2001-10-10 Shiseido Co Ltd Hair tonic
TW200524588A (en) * 2003-09-22 2005-08-01 Nippon Shinyaku Co Ltd Hair restorer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4210663A (en) * 1978-11-08 1980-07-01 Pfizer Inc. Halogen substituted benzopyran- and benzothiopyran-4-carboxylic acids
CH674984A5 (en) * 1987-05-16 1990-08-15 Sandoz Ag

Also Published As

Publication number Publication date
AU1256192A (en) 1992-09-15
WO1992014439A1 (en) 1992-09-03
TW260665B (en) 1995-10-21

Similar Documents

Publication Publication Date Title
EP0420707B1 (en) Compositions to be used to reduce hair-loss and to induce and stimulate its growth, containing derivatives of 2-aminopyrimidine 3-oxide and new compounds derived from 2-aminopyrimidine 3-oxide
UA119147C2 (en) Sulfonamides as modulators of sodium channels
CN101415716A (en) Condensed imidazole derivatives as aldosterone synthase inhibitors
EP4194452A1 (en) Aromatic compound and application thereof in antitumor drug
AU2015367531B2 (en) Bicycloheteroaryl-heteroaryl-benzoic acid compounds as retinoic acid receptor beta (RARbeta) agonists
KR20050057647A (en) Imidazole derivatives and their use as peripherally-selective inhibitors of dopamine-beta-hydroxylase
JP2002540207A (en) Pyrimido [6,1-a] isoquinolin-4-one derivatives
EP0370901A1 (en) Central nervous system active chromane derivatives, process for their preparation and pharmaceutical compositions containing them
WO1992012144A1 (en) Condensed benzoxa ring compound, production thereof, and pharmaceutical composition containing the same
Atwal et al. Cardioselective Antiischemic ATP-Sensitive Potassium Channel Openers. 2. Structure-Activity Studies on Benzopyranylcyanoguanidines; Modification of the Benzopyran Ring
JP2002511459A (en) Chromanone and thiochromanone derivatives
PL166007B1 (en) Method of obtaining novel derivatives of cyanoguenidine
US5412117A (en) Benzopyran derivatives
PT98019A (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS CONTAINING DERIVATIVES AND BENZOPIRAN AND HETEROCYCLIC ANALOGUES OF THE SAME USED AS ANTI-ISCHEMIC AGENTS
JP3255411B2 (en) Hair growth promoter
US5929082A (en) Potassium ion channel blockers
KR960014797B1 (en) Benzopyran derivative, production thereof, and pharmaceutical composition containing the same
Radhi et al. New barbiturate derivatives as potent in vitro α-glucosidase inhibitors
US7071205B2 (en) 5-cycloalkenyl 5H-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds
JPH05186458A (en) New benzopyran derivative
JP4430749B2 (en) Sulfonamide-substituted benzopyran derivatives, processes for their preparation, their use as medicaments and pharmaceutical formulations containing them
JPH02184686A (en) Novel benzopyranylpyrrolinone derivative
EP4209492A1 (en) Compound for treating thrombotic diseases
Pirotte et al. 4-Phenylureido/thioureido-substituted 2, 2-dimethylchroman analogs of cromakalim bearing a bulky ‘carbamate’moiety at the 6-position as potent inhibitors of glucose-sensitive insulin secretion
ZA200610702B (en) Hair growth promoting agents

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees